Stockwinners Market Radar for May 29, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
MESO | Hot Stocks21:02 EDT Mesoblast initiates BLA submission to FDA for remestemcel-L in aGVHD - Mesoblast announced that it has filed the first component of a rolling submission for a Biologics License Application, or BLA, to the FDA for remestemcel-L in the treatment of children with steroid-refractory acute graft versus host disease, or aGVHD, a life-threatening complication of an allogeneic bone marrow transplant. The FDA has agreed to a rolling review of the BLA which enables individual components to be submitted and reviewed on an ongoing basis rather than waiting for all sections to be completed. The rolling process will provide opportunity for ongoing communication, and during this process the company expects it will be able to adequately address any substantial matters raised by the FDA. Remestemcel-L has received Fast Track designation for aGVHD and under this designation Mesoblast intends to request a priority review once its BLA filing is completed and accepted by the FDA.
|
EIDX | Hot Stocks19:23 EDT Eidos Therapeutics CEO acquires about 1.1M common shares - In a regulatory filing, Eidos Therapeutics CEO Neil Kumar disclosed the acquisition of about 1.1M common shares of the company at a price of $25.93 per share.
|
IO | Hot Stocks19:07 EDT ION Geophysical CEO Brian Hanson to retire - ION Geophysical announced the retirement of Brian Hanson, its President and CEO, and his resignation from its board, both effective June 1, 2019, and the appointment of Chris Usher, previously Executive Vice President of ION's Operations Optimization segment, to succeed Mr. Hanson as President and CEO. Mr. Usher has also been elected to serve on the board.
|
ARWR | Hot Stocks19:04 EDT Arrowhead's O'Brien sells 30,000 common shares - In a regulatory filing, Arrowhead Pharmaceuticals General Counsel Patrick O'Brien disclosed the sale of 30,000 common shares of the company at a price of $24.88 per share.
|
KEYS... | Hot Stocks19:00 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Keysight Technologies (KEYS) up 7.8%... Veeva Systems (VEEV) up 7.1%... Verint Systems (VRNT) up 1.8%. ALSO HIGHER: electroCore (ECOR) up 30.6% after announcing redeployment and cost reduction plan. DOWN AFTER EARNINGS: Tilly's (TLYS) down 12.0%... PVH Corp (PVH) down 10.5%... Descartes Systems (DSGX) down 5.9%... Palo Alto Networks (PANW) down 5.0%. ALSO LOWER: Amicus Therapeutics (FOLD) down 6.6% after equity offering... Twilio (TWLO) down 3.0% after equity offering... Enphase Energy (ENPH) down 2.0% after equity offering. Movers as of 18:45ET.
|
AGCO | Hot Stocks18:58 EDT Agco CEO: Optimistic a U.S.-China trade deal can be completed - In an interview on CNBC's Mad Money, Agco CEO Martin Richenhagen said: Our focus this year is on margin improvement... We want 8% margin this year and 10% next year... We are very much a global company... We have the finest products in the industry... The Chinese seek long term relationships, they tend to be loyal... The American farmer is doing a great job.
|
NETS | Hot Stocks18:52 EDT Netshoes receives revised unsolicited proposal from Grupo SBF - Netshoes announced that it has received on May 28, 2019 a revised unsolicited proposal from Grupo SBF S.A., a sociedade anonima incorporated under the laws of Brazil and with shares listed in the Brazilian stock exchange under ticker "CNTO3," for purchase of all of the outstanding common shares of Netshoes through a merger transaction pursuant to which Netshoes shareholders would receive a payment in cash of $3.50 for each share of Netshoes common stock. Centauro's offer also set forth other features to address specific concerns previously raised by Netshoes as to its prior offer. amendment to the Agreement and Plan of Merger dated April 29, 2019 with Magazine Luiza S.A. and its wholly-owned subsidiary located in the Cayman Islands, pursuant to which Magazine Luiza S.A. would acquire all of the outstanding common shares of Netshoes at a price of $3.00 per share in cash for each common share Netshoes notified Magazine Luiza S.A. of the receipt of the revised Centauro proposal. In accordance with the terms of the Merger Agreement and its fiduciary obligations under the laws of the Cayman Islands, and in consultation with its financial and legal advisors, Netshoes' board of directors will carefully review Centauro's revised proposal to determine the course of action that it believes is in the best interest of the Netshoes' shareholders. Pending the completion of such review, the Netshoes board has not made any determination as to whether Centauro's revised proposal constitutes a superior proposal under the terms of the Merger Agreement. Accordingly, the board reaffirms its existing recommendation of the transaction with Magazine Luiza S.A. without qualification.
|
LOGI | Hot Stocks18:40 EDT Logitech CEO: All of our businesses are recession-resistant - In an interview on CNBC's Mad Money, Logitech CEO Bracken Darrell said: Gaming, video everywhere, and peripherals are long term drivers of our business... We are complimentary to Zoom's products... We are moving some manufacturing out of China... We will raise prices if we have to... We want to be the peripheral of choice for the virtual reality world.
|
PVH | Hot Stocks18:30 EDT PVH Corp. CEO: Tariffs and trade dispute haven't hit us yet - In an interview on CNBC's Mad Money, PVH Corp. CEO Emanuel Chirico said: We've really seen some softness in the business at the end of Q1, beginning of Q2... We're looking for a turnaround in the second half of the year... The tariffs haven't hit us yet... We're seeing a slowdown in growth and retail sales... The big impact in the U.S. is the strong dollar... There is a lack of international tourism... Rhetoric around trade is impacting consumer spending... There is no walking away from the fact that the consumer is feeling pressure both in the U.S. and China... Our digital business continues to be very strong.
|
RESI | Hot Stocks18:17 EDT Front Yard Residential director Dobbs bought 10K shares of common stock - In a regulatory filing, Front Yard Residential disclosed that its director Rochelle Dobbs bought 10K shares of common stock on May 24th. The total transaction size was $116K.
|
MDT | Hot Stocks18:12 EDT Medtronic director Hoedt sells 9K shares of common stock - In a regulatory filing, Medtronic disclosed that its EVP and President of EMEA, Rob Hoedt, sold 9K shares of common stock on May 28th. The total transaction size was $827K.
|
GLD | Hot Stocks17:34 EDT SPDR Gold Shares holdings rise to 740.86MT from 737.34MT - This is the highest level of holdings since May 2nd.
|
TKR | Hot Stocks17:29 EDT Timken awarded $147.43M Navy contract modification - Timken has been awarded a $147.43M firm-fixed-price modification to a previously awarded contract to exercise options for main reduction gear shipsets for Arleigh Burke class guided missile destroyers. The main reduction gear shipsets are the set of gears that transmit the power from two main propulsion gas turbines to the propulsion shaft. Each Arleigh Burke class guided missile destroyer has two gear assemblies; one for each propulsion shaft. Work is expected to be complete by November 2022. FY19 shipbuilding and conversion funding in the amount of $147.43M will be obligated at time of award and will not expire at the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity.
|
RDS.A | Hot Stocks17:25 EDT Royal Dutch Shell awarded $197.91M Defense Logistics Agency contract for fuel - Shell has been awarded a $197.91M fixed-price with economic-price-adjustment contract for fuel. This was a competitive acquisition with 18 responses received. These are one-year contracts with a 30-day carry-over period. Work has a July 30, 2020, performance completion date. Using customer is Defense Logistics Agency Energy. Type of appropriation is FY19 defense working capital funds. The contracting activity is the Defense Logistics Agency Energy.
|
RILY | Hot Stocks17:22 EDT B. Riley Financial CAO sells 10K shares of common stock - In a regulatory filing, B. Riley Financial disclosed that its Chief Accounting Officer Howard Weitzman sold 10K shares of common stock on May 24th. The total transaction size was $195K.
|
ADES | Hot Stocks17:05 EDT Advanced Emissions announces additional refined coal facility closure - Advanced Emissions Solutions announced that Tinuum Group, a joint venture among the company's subsidiary ADA-ES, Inc., an affiliate of NexGen Resources Corporation, and an affiliate of The Goldman Sachs Group,, has completed a transaction for an additional Refined Coal facility. The RC facility is located at a coal-fired power plant that has historically burned in excess of 3.1M tons of coal per year and is royalty bearing to ADES. With this addition, Tinuum Group has 21 invested facilities in full-time operation. L. Heath Sampson, President and CEO of ADES, commented, "The momentum that began to build late last year in our RC segment has carried over into 2019. I am pleased Tinuum has secured a tax-equity investor for an additional facility, bringing the total number of operational units to 21 and making it the second contracted refined coal facility in 2019. The cadence of closures this year is consistent with our previously outlined expectations, and we continue to maintain visibility into an additional 5 to 6 million tons, in 2019, that have the potential to add to our future projected cash flows from this business. We have worked closely alongside Tinuum as they have diligently worked to educate prospective investors around the benefits and importance of refined coal in helping curtail harmful emissions, and we are pleased to see these efforts translate into shareholder value."
|
ZYME | Hot Stocks17:00 EDT Zymeworks' ZW25 granted fast track designation by FDA - Zymeworks Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation to ZW25, a novel Azymetric bispecific antibody, for the first-line treatment of patients with HER2-overexpressing gastroesophageal adenocarcinoma in combination with standard of care chemotherapy. "Receipt of Fast Track designation from the FDA emphasizes the large unmet need of patients with these types of HER2-expressing cancers," said Ali Tehrani, Ph.D., Zymeworks' President & CEO. "This designation is key to our objective of getting important new therapies to patients as quickly as possible. We are pleased with the discussions we've had with the FDA thus far and will continue to work together on other opportunities to accelerate the development of ZW25 in additional indications."
|
ECOR | Hot Stocks17:00 EDT electroCore Inc trading resumes
|
O | Hot Stocks16:56 EDT Realty Income EVP Pfeiffer sells 10.8K shares of common stock - In a regulatory filing, Realty Income disclosed that its EVP and Chief Admin Officer Michael Pfeiffer sold 10.8K shares of common stock on May 28th. The total transaction size was $756K.
|
BCRX | Hot Stocks16:51 EDT Integrated Core Strategies reports 5.6% passive stake in BioCryst - In a regulatory filing, Integrated Core Strategies disclosed a 5.6% stake in BioCryst, which represents about 6.2M shares. The filing does not allow for activism.
|
AIG | Hot Stocks16:48 EDT AIG names Sharon French as President/CEO of Life & Retirement Funds - AIG announced the appointment of Sharon French as President and CEO of Life & Retirement Funds. Ms. French succeeds Peter Harbeck, who announced his intention to retire late last year. In her new role, Ms. French will lead the Life & Retirement Funds business, which comprises both AIG's retail mutual funds operation and SunAmerica Asset Management, LLC, which manages and administers over $85B in assets across multiple Life & Retirement business lines. Ms. French will assume her new position in late June.
|
LOOP | Hot Stocks16:46 EDT Loop Industries announces $35M capital infusion from Northern Private Capital - Loop Industries announced that Toronto-based Northern Private Capital has made a binding commitment to purchase 4.1M shares of Loop's common stock at a price of $8.55 per share, for total net proceeds of approximately $35M. After giving effect to the transaction, NPC will have a 10.5% ownership position in Loop's common equity. The transaction is expected to close in twelve business days, on or about June 14. In addition, Loop has granted NPC a 3-year option that will vest six months following the closing to acquire an additional 4.1M common shares at a price of $11 per share, which would result in further total net proceeds of approximately $45 million.
|
ECOR | Hot Stocks16:38 EDT ElectroCore announces redeployment, cost reduction plan - ElectroCore announced that management and the board are making adjustments to the deployment of personnel and resources across the organization. The effort is intended to focus the company on currently available and near-term revenue opportunities and on clinical programs specifically designed to expand the gammaCore product labeling. To achieve this goal the company is right-sizing across its organization, including its field sales force and clinical operations. The company will focus its resources on high-value geographic and other sales territories where the current prescriber base and regional payer coverage are most concentrated including regional payers, some of whom have recently amended their policies to permit reimbursement for electroCore's principal offering. The Veterans Administration and Department of Defense, covered under the Federal Supply Schedule contract was secured by the company in December 2018. Resources also include The United Kingdom, where a recent innovative technology program cluster headache treatment award offers the company the potential to generate revenue. The company will continue to pursue relationships with pharmacy benefit managers. ElectroCore also announced that it is scaling back its clinical development program as part of the redeployment of resources. Changes include the postponement of several planned studies while focusing on opportunities to broaden the approved indications for gammaCore products. The company is also reducing its medical affairs activities consistent with its revised commercial plan. The broad-based redeployment and expense reduction plan will be fully implemented by the end of Q2. Beginning in Q3, the company's average quarterly cash burn is expected to be less than $7M through 2020, compared to its previously reported expected burn of $12M per quarter. Inclusive of one-time charges of approximately $350,000 associated with implementation of this plan, the company's Q2 cash burn is expected to be between $11M and $11.5M. This expense reduction plan is further bolstered by the decision of the company's independent directors to forgo all cash compensation for their board service effective June 1, as well as the willingness of Frank Amato, the company's CEO, to voluntarily accept a 10% reduction in base annual cash compensation for the next 12 months, which is expected to be offset by a grant of restricted stock units valued at $50,000 on June 7, the date of the company's annual meeting of stockholders. On March 31, the company had $52.4M of cash, cash equivalents and marketable securities. Based on its current cash resources and cash flow projections, and after giving effect to the anticipated cost savings from the comprehensive redeployment and cost reduction plan, electroCore believes that it will have adequate resources to fund its operations into the beginning of 2021.
|
PVH | Hot Stocks16:36 EDT PVH Corp. down 7% to $92.50 after cutting FY19 profit outlook - The company's Q2 profit guidance also missed estimates.
|
FC | Hot Stocks16:35 EDT Franklin Covey director sells 4.3K shares of common stock - In a regulatory filing, Franklin Covey disclosed that its director Esther Kay Stepp sold 4.3K shares of common stock on May 29th. The total transaction size was $134K.
|
PANW | Hot Stocks16:34 EDT Palo Alto Networks down 4% to $205.50 after Q4 profit guidance trails estimates
|
PTGX | Hot Stocks16:30 EDT Protagonist Therapeutics names Dan Kalkofen CFO - Protagonist Therapeutics, Inc. announced the appointment of Don Kalkofen as Chief Financial Officer. Prior to joining the Protagonist Therapeutics team, Kalkofen served in an advisory role as Senior Advisor, Finance, to the company.
|
ECOR | Hot Stocks16:25 EDT electroCore Inc trading halted, news pending
|
NSP | Hot Stocks16:23 EDT Insperity CEO sells 10,000 common shares - In a regulatory filing, Insperity chairman and CEO Paul J. Sarvadi disclosed the sale of 10,000 common shares of the company at a price of $114.03 per share.
|
CNXN | Hot Stocks16:20 EDT Connection Public Sector Solutions awarded DoD contract - Connection announced that Connection Public Sector Solutions is one of six major IT solution providers selected for a multiple-award, firm-fixed price blanket purchase agreement in accordance with a General Services Administration Federal Supply Schedule contract. The combined contracts have an estimated value of $3.17B and will provide commercially available Microsoft brand name perpetual software licenses and annual subscriptions for the Department of Defense, U.S. intelligence community, and U.S. Coast Guard. The ordering period will run through November 27, 2028. Robert Howard, President of Connection Public Sector Solutions, stated, "This agreement highlights Connection's contract expertise and extensive experience helping Federal customers navigate an increasingly complex Microsoft licensing landscape. We will continue to deliver the exceptional value, service, and trusted guidance that make Connection the go-to IT provider for those looking to transform their organizations and achieve greater performance, efficiency, and security."
|
PANW | Hot Stocks16:19 EDT Palo Alto Networks CEO says 'excitement around our new products is incredible' - "Our team continues to execute on our plan and deliver robust results. The excitement around our new products is incredible and will only grow once customers have a chance to experience it for themselves," said Nikesh Arora, chairman and CEO of Palo Alto Networks. "Both Twistlock and PureSec will be important additions to helping protect our customers' journey to the cloud. Combining their capabilities with Prisma, our leading cloud security suite, is a huge win for all of our customers."
|
PVH | Hot Stocks16:19 EDT PVH reports Q1 Tommy Hilfiger revenue up 4% to $1.1B - Reports Q1 Calvin Klein revenue flat at $890M. Reports Q1 Heritage Brandns revenue up 1% to $415M.
|
PANW | Hot Stocks16:19 EDT Palo Alto Networks to acquire Twistlock and PureSec security companies - Palo Alto Networks has entered into definitive agreements to acquire Twistlock, a provider of container security, and PureSec, a provider of serverless security, to extend its Prisma cloud security strategy. Palo Alto Networks will pay approximately $410M in cash, subject to adjustments, to acquire Twistlock. Twistlock combines vulnerability management, compliance, and runtime defense for cloud-native applications and workloads. The company serves more than 290 customers. Twistlock co-founders, Ben Bernstein and Dima Stopel, will join Palo Alto Networks. PureSec provides end-to-end security for serverless functions that cover vulnerability management, access permissions, and runtime threats. PureSec co-founders, Shaked Zin, Ory Segal, and Avi Shulman, will join Palo Alto Networks. Terms of the PureSec transaction were not disclosed. Both acquisitions are expected to close during Palo Alto Networks Q4.
|
PANW | Hot Stocks16:18 EDT Palo Alto Networks reports deferred revenue grows 27% y/y to $2.6B
|
AGNC | Hot Stocks16:17 EDT AGNC Investment CEO Gary Kain buys over $1.7M in company shares - AGNC Investment CEO Gary Kain disclosed in a filing that he had purchased 103,202 shares of company stock at $16.93 per share between May 24 and May 28.The total transaction value of the purchase was $1,747,530.
|
AMAL | Hot Stocks16:16 EDT Amalgamated Bank announces $25M stock buyback program - Amalgamated Bank announced that its board has authorized the repurchase of up to $25M of the company's Class A common stock. The company intends to fund the program with a combination of cash on hand and cash generated from operations.
|
RTW | Hot Stocks16:11 EDT RTW Retailwinds names Traci Inglis chief marketing and customer officer - RTW Retailwinds announced the appointment of Traci Inglis as President, Chief Marketing and Customer Officer, effective June 10, 2019, reporting directly to Gregory Scott, CEO of RTW Retailwinds, Inc. In this newly created position, Inglis will be responsible for the entire customer journey including acquisition along with utilizing customer and digital analytics to strengthen all aspects of the company's customer, marketing, and digital initiatives. Gregory Scott, RTW Retailwinds, Inc. CEO, stated, "We are pleased to welcome Traci to the RTW Retailwinds executive team. Traci has demonstrated an innate ability to translate analytics and insights into innovative, customer-first strategies. Traci joins us at an important time in our multi-brand evolution and in this newly created role, she will develop and guide an elevated customer journey with a focus on driving new and engaging existing customers across our brand portfolio. Her experience will be incredibly important to our portfolio of brands as we work to reinvent the way we market and deliver experiences to our customers across all channels. We have recently introduced two digitally native brands, Happy x Nature and Uncommon Sense, which combined with the ongoing success of our Fashion to Figure brand and the strength of our core New York & Company business will benefit from Traci's deep expertise in leveraging data and customer analytics to drive profitable growth. I look forward to working with her on building for the future of RTW Retailwinds and transforming our customer journey across our portfolio of brands."
|
KEYS | Hot Stocks16:10 EDT Keysight Technologies announces new $500M share repurchase program - Keysight announced that its board authorized a new share repurchase program for up to $500M of its common stock. The new repurchase program is effective immediately and replaces the previously authorized $350M program from 2018 of which $160M remained. Shares may be purchased from time to time, subject to general business and market conditions and other investment opportunities, through open market purchases, privately negotiated transactions or other means. The repurchase authorization may be commenced, suspended or discontinued at any time at the company's discretion.
|
UBX | Hot Stocks16:08 EDT Unity Biotechnology, UCSF in licensing pact on alpha-Klotho Ppotein - UNITY Biotechnology announced that UNITY executed an exclusive, worldwide license to UCSF intellectual property relating to the alpha-Klotho protein, a circulating factor associated with improved cognitive performance.The alpha-Klotho protein was initially identified in mice as an "aging-suppressor" that accelerates aging when the gene encoding it is disrupted, and slows aging when the alpha-Klotho protein is over-produced. In a 2017 report, Dena Dubal, M.D., Ph.D., David A. Coulter Endowed Chair in Aging and Neurodegenerative Disease at UCSF, and other authors, reported that when the alpha-Klotho protein was injected into mice it reversed the deleterious effects of aging and age-related disease on cognition.
|
BOLD | Hot Stocks16:05 EDT Audentes Therapeutics announces changes to senior management team - Audentes Therapeutics has appointed Edward Conner as Senior VP and Chief Medical Officer and promoted Fulvio Mavilio to Senior VP of Translational Science. Suyash Prasad, Senior VP and Chief Medical Officer and John Gray, Senior VP and Chief Technology Officer are leaving Audentes. Edward Conner's appointment is effective July 15. He joins Audentes from Sangamo Therapeutics, where he served as Senior VP and Chief Medical Officer and led the clinical development of the company's pipeline of genomic therapies. Fulvio Mavilio joined Audentes in 2017 from Genethon where he served as Chief Scientific Officer and led the development of a pipeline of gene therapy programs.
|
BWFG | Hot Stocks16:03 EDT Bankwell Financial CLO Heidi DeWyngaert to retire - Heidi DeWyngaert will retire from her role as EVP, chief lending officer, or CLO, at Bankwell, a job she has held for the last fifteen years. DeWyngaert's retirement was announced at Bankwell's annual shareholder meeting. She will remain with the bank through year end and will help coordinate an effective transition as Bankwell begins a search for an addition to its executive team.
|
GOOG GOOGL | Hot Stocks15:37 EDT Google prohibits marijuana delivery apps from Play Store - Alphabet's Google has updated its Google Play Store content policy to say that it doesn't allow apps that facilitate the sale of marijuana or marijuana products, regardless of legality. Google listed some examples of common violations, including: allowing users to order marijuana through an in-app shopping cart feature; assisting users in arranging delivery or pick up of marijuana; and facilitating the sale of products containing THC. Reference Link
|
ATVI | Hot Stocks15:35 EDT Activision teases 'Call of Duty' announcement with 'Going Dark' tweet - Activision has teased its official "Call of Duty" announcement for May 30 with a tweet on the game's official Twitter account. .Reference Link
|
GENE | Hot Stocks15:24 EDT Genetic Technologies granted patent in Europe for gene mapping - Reference Link
|
NAV | Hot Stocks15:18 EDT Navistar takes $159M charge for class action settlement over engines marketing - Navistar disclosed earlier today that it entered into a settlement agreement with certain named plaintiffs to settle the putative class action lawsuits pending in the United States that were previously consolidated in the United States District Court for the Northern District of Illinois as "In re Navistar MaxxForce Engines Marketing, Sales Practices and Products Liability Litigation." On May 28, plaintiffs submitted the settlement agreement to the court for preliminary approval. The U.S. class actions allege that certain MaxxForce Advanced EGR engines are defective and that Navistar failed to disclose or correct the alleged defect. Pursuant to the settlement agreement, the parties will establish a non-reversionary common fund consisting of cash and rebates with a total value of $135M. Navistar will contribute $85M to the cash fund, which will be used to pay all settlement fees and expenses, service awards, attorneys' fees and costs, and cash payments to members of the settlement class. The company will also commit to make available rebates with a face value in the aggregate of $50M to the rebate fund. The settlement class will release Navistar and its affiliates from all claims and potential claims arising from or related to the allegations in the U.S. class actions, except for claims for personal injury or damage to third-party property. Navistar has recorded a charge in its fiscal Q2 in the amount of $159M for its expected obligations under the settlement agreement, as well as for current period liabilities and potential future settlements with respect to certain other MaxxForce Advanced EGR engine lawsuits that are not included in the agreement.
|
AXELF KKR | Hot Stocks15:03 EDT Axel Springer confirms talks with KKR for strategic investment - Axel Springer (AXELF) announces that its Executive Board is in negotiations with Kohlberg Kravis Roberts (KKR) as well as Dr. h.c. Friede Springer for a potential strategic investment of KKR in Axel Springer. It added, "The state of negotiations provides KKR to launch a public tender offer to the other shareholders of Axel Springer SE to acquire their shares after KKR has agreed on a consortium with companies held by Dr. h.c. Friede Springer and chief executive offer Dr. Mathias Doepfner. Dr. h.c. Friede Springer, majority shareholder Axel Springer Gesellschaft fuer Publizistik GmbH & Co which is held by Dr. h.c. Friede Springer and Dr. Mathias Doepfner do not intend to sell their shares in Axel Springer SE in the course of the transaction. By this exploration, the Executive Board is pursuing its growth strategy of increasing the enterprise value in the long-term. KKR as long-term orientated investor acting jointly in a consortium with Dr. h.c. Friede Springer and Dr. Mathias Doepfner will support this strategy. In the view of the Executive Board, it is currently open whether there will be a public tender offer and an investment by KKR in Axel Springer SE or any subsequent corporate structural measures. In particular, legal, tax and financial feasibility still needs to be reviewed in detail by the parties involved.
|
TWTR | Hot Stocks14:39 EDT Twitter announces update to live video 'Go live with guests!' - According to the Twitter blog: "Conversations on Twitter can take place in many ways, and our latest update to live video brings another dimension to how you can discuss what's happening. Starting today, your Tweets are going #IRL and now you can host a live video and invite up to three people as guests. Those you allow to join can be heard by everyone and can drop off at any time. Whether its #NBATwitter or #DemThrones, you can discuss your interests with anyone around the world and actually hear their perspective and reactions in real-time. Get a step-by-step guide on how to go live together here.We've learned how valuable the audio experience is for people to discuss topics they care about, because when you can chat live together, it's more fun! We're thinking about ways we can add video for guests too, so stay tuned. Check it out, tap the smilies and go live with guests on Twitter." Reference Link
|
WFC... | Hot Stocks14:30 EDT Wells Fargo names former BofA CFO Noski to board of directors - Wells Fargo (WFC) announced that Charles H. Noski has been elected to the company's board of directors, effective June 1, 2019. Noski will serve on the board's Audit and Examination Committee. Noski currently serves as a director and chairman of the audit committees of Booking Holdings Inc. (BKNG) and Microsoft (MSFT). During his business career, Noski has served in numerous senior leadership roles, including as vice chairman of Bank of America (BAC), where he also served as executive vice president and chief financial officer.
|
GOOG GOOGL | Hot Stocks14:27 EDT Gmail confidential mode is launching on June 25 - Gmail confidential mode is launching on June 25 by default, according to Google's G Suite team. According to the posting by G Suite: "Earlier this year, we announced the launch of Gmail confidential mode for G Suite in beta. On June 25, 2019, this feature will become generally available and your users will have the option to send emails with confidential mode. At launch, confidential mode will be set to default ON for all domains with Gmail enabled. Who's impacted: Admins and end users.Why you'd use it:Confidential mode provides built-in information rights management controls in your emails by allowing senders to create expiration dates and revoke previously sent messages. Because a sender can require additional authentication via text message to view an email, it's also possible to protect data even if a recipient's email account has been hijacked while the message is active. Additionally, with confidential mode, recipients don't have the option to forward, copy, print, or download their content or attachments." Reference Link
|
CRM | Hot Stocks13:16 EDT Salesforce announces 'low-code' blockchain platform at developer conference - Salesforce announced Salesforce Blockchain, what it says is a "low-code platform that enables organizations to share verified, distributed data sets across a trusted network of partners and third parties." Salesforce Blockchain made its debut today at TrailheaDX, Salesforce's fourth annual developer conference. "We help companies build for the future by making breakthrough technology accessible and easy to use-today we are doing just that with Salesforce Blockchain," said Bret Taylor, President and Chief Product Officer, Salesforce. "Now, companies will be able to create new ecosystems and achieve new levels of interconnectivity through trusted partner networks."
|
PHG | Hot Stocks13:09 EDT Philips says latest trial data add to confidence in Stellarex program - Royal Philips announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE European randomized clinical trial, EU RCT. These two trials are part of a series of five trials evaluating the safety and efficacy of Stellarex .035 low-dose DCB to restore and maintain blood flow in the superficial femoral artery and popliteal arteries of patients with peripheral arterial disease. The results were evaluated compared to treatment with uncoated balloons, the current standard of care. "The three year data of the ILLUMENATE Pivotal trial and ILLUMENATE EU RCT add to the robust and consistent multi-year data of the Stellarex program," said S. Jay Mathews, M.D. "The demonstrated durability of Stellarex in the complex patient pool of the ILLUMENATE Pivotal trial, which are patients that are at high risk for restenosis, a recurring blockage, is unique in the industry. Moreover, we continue to see no significant difference in mortality rates between patients treated with Stellarex and those treated with uncoated balloons, which confirms our confidence in the safety profile of Stellarex." "We are committed to providing clinically proven image-guided therapy solutions that enhance the procedure and positively impact patient outcomes," said Bert van Meurs, Chief Business Leader, Image Guided Therapy at Royal Philips. "Stellarex is the only low-dose drug-coated balloon with a proven treatment effect at three years compared to the existing standard-of-care in the U.S. and Europe. The combination with our interventional imaging systems, such as the successful Azurion platform, our recently-introduced IntraSight intravascular diagnostic application platform, and associated services, enables clinicians to decide, guide, treat and confirm the appropriate peripheral vascular treatment."
|
XOM | Hot Stocks12:54 EDT Exxon Mobil sees doubling of potential annual cash flow from operationd by 2025 - ExxonMobil expects to increase annual earnings potential by more than 140% and double potential annual cash flow from operations by 2025 from 2017 adjusted earnings, assuming a 2017 oil price of $60 per barrel adjusted for inflation and based on 2017 margins. "ExxonMobil is progressing growth plans to substantially increase earnings and cash flow potential while researching technology breakthroughs to reduce emissions, Chairman and CEO Darren Woods told shareholders during the company's annual meeting . "We are committed to sharing the company's success with our shareholders," said Woods. "Higher earnings and increased cash flow from our investments are a good means to accomplish this. We are equally committed to helping society reduce global emissions while supporting growth and prosperity for communities around the world - effectively addressing the dual challenge...The world needs additional solutions," he said. "That's where we think we can add significant value - leveraging ExxonMobil's experience in the global energy system and our strong foundation in research and development," Chairman and CEO Darren Woods told shareholders.
|
HMST | Hot Stocks12:10 EDT HomeStreet board sends letter to shareholders critical of Roaring Blue Lion - The Board of HomeStreet sent a letter to shareholders in connection with the company's upcoming 2019 Annual meeting of shareholders, which is scheduled to be held on June 20. The letter said in part: "Unfortunately, activist hedge fund Roaring Blue Lion Capital Management is seeking to replace two essential Board members, Chairman and CEO Mark Mason and Lead Independent Director Donald Voss, with two less qualified candidates...We believe Roaring Blue Lion has misrepresented not only the track records and qualifications of Messrs. Mason and Voss, but also the roles these proven leaders play on HomeStreet's Board...Our recently announced decision to exit the large-scale home loan center-based mortgage banking business will allow us to focus even more intently on furthering the success of our Commercial and Consumer Banking Business. Additionally, this transition will provide more portfolio space for commercial lending going forward...Donald Voss, as Lead Independent Director and Mark Mason, as our Chairman and CEO - both of whom Roaring Blue Lion has targeted for removal - are the elected leaders of our Board and Company. Removing these two directors and replacing them with less qualified substitutes would be highly damaging and detrimental to the HomeStreet Board."
|
SYNL | Hot Stocks12:03 EDT Synalloy rejects unsolicited offer by Privet Fund Management - Synalloy Corporation announced that the Executive Committee of its Board of Directors, acting on behalf of the Board of Directors, after deliberation and careful consultation with its independent financial and legal advisors, once again rejected an unsolicited offer by Privet Fund Management for a proposed transaction whereby Privet would purchase all of the issued and outstanding shares of Synalloy not already owned by Privet. Privet's most recent offer was unchanged and simply reiterated its offer dated April 23, 2019. "The Board believes that Privet has two options at this point," said CEO Craig Bram. "Privet should either negotiate with the Executive Committee of the Board to determine an acceptable price, or tender for the shares and let the shareholders vote directly on the offer. This back and forth letter writing about an inadequate $20 per share offer is distracting and counter to our goal of building shareholder value,"
|
ARRY | Hot Stocks12:00 EDT Array BioPharma to present data from Phase 3 COLUMBUS trial at ASCO - Array BioPharma announced that that it will present data from the Phase 3 COLUMBUS Trial of BRAFTOVI + MEKTOVI in advanced BRAF-mutant melanoma in an oral poster discussion on June 3, 2019, at the 55th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. Landmark overall survival and progression-free survival, as well as subgroup analyses and updated safety and tolerability, will be presented. Across arms, median follow-up for OS was 48.6 months, with a median OS of 33.6 months for BRAFTOVI, 450 mg daily + MEKTOVI, 45 mg twice daily, compared to 16.9 months for vemurafenib, consistent with prior readouts. Compared to vemurafenib, BRAFTOVI, 450 mg daily + MEKTOVI, 45 mg twice daily, decreased the risk of death by 39%. Updated median progression-free survival also remained consistent and was 14.9 months with BRAFTOVI, 450 mg daily + MEKTOVI, 45 mg twice daily, compared to 7.3 months with vemurafenib HR, 0.52.
|
ANF | Hot Stocks12:00 EDT Abercrombie & Fitch falls -24.7% - Abercrombie & Fitch is down -24.7%, or -$6.18 to $18.82.
|
EVH | Hot Stocks12:00 EDT Evolent Health falls -25.8% - Evolent Health is down -25.8%, or -$3.66 to $10.49.
|
GOOS | Hot Stocks12:00 EDT Canada Goose falls -26.4% - Canada Goose is down -26.4%, or -$12.95 to $36.07.
|
ZYME | Hot Stocks12:00 EDT Zymeworks rises 5.1% - Zymeworks is up 5.1%, or 90c to $18.43.
|
HEI | Hot Stocks12:00 EDT Heico rises 9.6% - Heico is up 9.6%, or $10.04 to $114.89.
|
NETS | Hot Stocks12:00 EDT Netshoes rises 18.7% - Netshoes is up 18.7%, or 57c to $3.62.
|
ADM | Hot Stocks11:14 EDT Archer Daniels creates Ag Services & Oilsees business unit - Archer Daniels Midland Company announced the creation of a new business unit called Ag Services & Oilseeds, which combines ADM's Origination and Oilseed business operations into a single reporting structure, effective July 1. The new business unit will be led by Greg Morris, formerly president, Oilseeds for ADM. "ADM's ability to provide value through the entire supply chain - from origination to processing to transportation to ingredients and solutions - is what sets us apart from others in the industry," said Chairman and CEO Juan Luciano. "Bringing the unparalleled strength of our global origination, global trade and destination marketing businesses and our transportation network together with our leadership in oilseeds processing and value-added product mix is a natural evolution. This helps us better integrate the supply and value chains to deliver significant simplification and efficiency to the day-to-day business."
|
LMT | Hot Stocks11:00 EDT Lockheed Martin CEO says company looking to opportunistically buyback stock - Lockheed Martin CEO Marillyn Hewson said the company is looking to "opportunistically buyback stock on dips."
|
PDCE | Hot Stocks10:52 EDT PDC Energy says shareholders re-elect Brookman, Ellis, Mazza to board - PDC Energy announced that, based on the preliminary vote count provided by its proxy solicitor following the company's 2019 Annual Meeting of Stockholders, PDC shareholders have voted to re-elect Barton R. Brookman, Mark E. Ellis, and Larry F. Mazza to the company's Board of Directors. PDC issued the following statement: "On behalf of the PDC Energy Board and management team, we thank our shareholders for their strong support. We greatly appreciate the thoughtful and constructive feedback we received throughout this process and look forward to continued engagement to advance our shared goal of creating value. We are pleased shareholders remain confident in our team and operating plan focused on capital discipline, free cash flow generation, profitable growth, and return of capital to shareholders. We look forward to capitalizing on the Company's high-quality assets and operational capabilities to deliver superior returns for investors and create long-term, sustainable value.The preliminary results indicate that shareholders approved all other proposals considered at the Company's Annual Meeting, including, on an advisory basis, the compensation of the Company's named executive officers and the ratification of PricewaterhouseCoopers, LLP as PDC Energy's independent auditor."
|
LMT | Hot Stocks10:51 EDT Lockheed Martin expects to sell over 4,600 F-35s over program life - Lockheed Martin CEO Marillyn Hewson said Poland, Spain, Romania, Slovakia are among potential F-35 buyers. Hewson said the company is building F-16 wings in India. Hewson added the company is in negotiations for the next multi-year C-130J contract with the U.S. Air Force. Hewson said the company is developing laser weapons systems.
|
CMG | Hot Stocks10:47 EDT Chipotle says 'definitely sees path' to 5,000 restaurants in U.S.
|
DKS... | Hot Stocks10:37 EDT Dick's Sporting says pleased with progress Under Armour has made
|
UBER | Hot Stocks10:28 EDT Uber says riders with 'significantly below average rating' may lose access - Uber said in a statement posted on its website, "When we created our global Community Guidelines in 2016, we had these common values in mind. Today we're refreshing these guidelines to make them simpler and clearer. Since everyone on our platform is expected to follow these guidelines, it's important to ensure people see and understand them...Riders may lose access to Uber if they develop a significantly below average rating. Riders will receive tips on how to improve their ratings, such as encouraging polite behavior, avoiding leaving trash in the vehicle and avoiding requests for drivers to exceed the speed limit. Riders will have several opportunities to improve their rating prior to losing access to the Uber apps. Respect is a two-way street, and so is accountability. Drivers have long been expected to meet a minimum rating threshold which can vary city to city. While we expect only a small number of riders to ultimately be impacted by ratings-based deactivations, it's the right thing to do." Reference Link
|
LMT | Hot Stocks10:26 EDT Lockheed Martin CEO says company working to reduce costs for F-35 - Lockheed Martin CEO Marillyn Hewson said the company is working to reduce the costs of the F-35 and is on track to reduce the flight hour costs to $25,000 from $35,000 and the F-35 expenses by 15% over 3 years. Hewson said the strength of Q1 was "surprising" both in sales and orders. Regarding the U.S. defense spending budget, Hewson said her understanding is that there is "good, positive dialogue" on defense spending. Hewson doesn't see a topline impact if there is a continuing budget resolution, as opposed to a budget. Comments provided during Bernstein Strategic Decisions Conference.
|
CMG | Hot Stocks10:21 EDT Chipotle says avocado 'supply not quite keeping up with demand' - Says not planning to raise prices because of pressure from avocados, says pressure is "cyclical." Says pork issue "a supply problem." Comments taken from Bernstein's 35th Annual Strategic Decisions Conference.
|
DKS | Hot Stocks10:19 EDT Dick's Sporting says impact of increased tariffs not factored into guidance - Says working through the impact of increase of tariffs. Says closely monitoring situation and hopeful trade deal can be reached.
|
DKS | Hot Stocks10:16 EDT Dick's Sporting continues to expect hunt to be negative in 2019 - Says continued to see meaningful sales decline in Hunt. Says continues to expect category to be negative in 2019 but is reducing exposure. Says on track to rework space in 125 stores in Q2.
|
DKS | Hot Stocks10:12 EDT Dick's Sporting says continues to execute against strategic priorities
|
DKS | Hot Stocks10:11 EDT Dick's Sporting says remains on track to open two e-commerce fulfillment centers - Says enthusiastic about business. Says e-commerce business remained strong. Says inventory is clean and well positioned. Says comp decline in hunt lessened, but category still meaningfully declined due to headwinds. Says remains on track to reallocate floor space in 125 additional stores. Says will continue review of hunt business. Says private brands are a source of strength. Says continues to focus on growing existing brands. Says remains focused on building best omnichannel experience. Says assortment will be more compelling in Q2. Comments taken from Q1 earnings conference call.
|
CY | Hot Stocks10:09 EDT Cypress Semiconductor trading resumes
|
MDT | Hot Stocks10:04 EDT Medtronic gains FDA clearance for new catheter system for HIS bundle pacing - Medtronic announced U.S. Food and Drug Administration clearance and commercial launch for the SelectSite C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing. Medtronic says the SelectSite C304-HIS deflectable catheter system features a "deflectable, out-of-plane curve to reach the bundle of His and is designed to enable enhanced range maneuverability, fixation and implant success for a wider range of patient anatomies. Its adjustable form helps accommodate and secure the pacing lead in more challenging anatomies, including patients with a large right atrium."
|
CY | Hot Stocks10:02 EDT Cypress Semiconductor jumps after Bloomberg report of takeover interest - Shares of Cypress Semiconductor jumped after Bloomberg reported that the company is weighing a sale after receiving takeover interest. Before halting for volatility, Cypress Semiconductor rose 7%, or $1.07, to $16.47 in morning trading following the report.
|
CY | Hot Stocks10:01 EDT Cypress Semiconductor jumps 7% to $16.47 after Bloomberg report of interest
|
SBS | Hot Stocks10:00 EDT Sabesp rises 5.4% - Sabesp is up 5.4%, or 57c to $11.17.
|
HEI | Hot Stocks10:00 EDT Heico rises 5.9% - Heico is up 5.9%, or $6.23 to $111.09.
|
NETS | Hot Stocks10:00 EDT Netshoes rises 17.2% - Netshoes is up 17.2%, or 53c to $3.58.
|
CY | Hot Stocks09:59 EDT Cypress Semiconductor trading halted, volatility trading pause
|
GIS | Hot Stocks09:55 EDT General Mills reports preliminary Q4 Pet segment net sales up 38% - In remarks at the 2019 Bernstein Strategic Decisions Conference, General Mills reported preliminary results for the Pet segment for fiscal 2019. On a pro forma basis, fourth-quarter Pet segment net sales increased 38%. Fourth-quarter segment operating profit increased 82% on a pro forma basis including $3M of purchase accounting charges and increased 88% excluding these charges. For the full year, Pet segment net sales increased 11%, and segment operating profit decreased 11% on a pro forma basis including $66% of purchase accounting charges and increased 11% excluding these charges. Pet segment results for the full fiscal year include 7 days from the month of acquisition. General Mills will report fiscal 2019 results for the total company, including final Pet segment results, in late June.
|
LCI | Hot Stocks09:47 EDT Lannett rises 3.3% - Lannett is up 3.3%, or 18c to $5.59.
|
GVA | Hot Stocks09:47 EDT Granite Construction rises 4.6% - Granite Construction is up 4.6%, or $1.83 to $41.94.
|
HEI | Hot Stocks09:47 EDT Heico rises 6.7% - Heico is up 6.7%, or $7.04 to $111.90.
|
LMNX | Hot Stocks09:44 EDT Luminex short position closed at Off Wall Street
|
SOLY | Hot Stocks09:43 EDT Soliton Inc trading resumes
|
MCD BYND | Hot Stocks09:41 EDT McDonald's CEO says taking serious look at plant-based meat - McDonald's (MCD) CEO Steve Easterbrook said on CNBC that his company is taking a serious look at plant-based meat products. Easterbrook spoke of the complexities in the kitchen of making such products. When asked if McDonald's would become a customer by the end of the year to a company like Beyond Meat (BYND), Easterbrook said he has "no idea."
|
C | Hot Stocks09:40 EDT Citi CEO says client engagement not suggesting recession is near
|
SOLY | Hot Stocks09:38 EDT Soliton Inc trading halted, volatility trading pause
|
C | Hot Stocks09:35 EDT Citi CEO says trading revenue, wallets 'right now are down'
|
BYD... | Hot Stocks09:33 EDT Nevada reports April statewide gaming win down 1.81% to $936.48M - Reports April Las Vegas Strip gaming win down 3.53% to $481.86M. Publicly traded companies in the casino space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).
|
TRNO | Hot Stocks09:29 EDT Terreno Realty acquires two properties in San Francisco for $47.8M - Terreno Realty Corporation acquired two industrial properties located in San Francisco, California on May 28, 2019 for a purchase price of approximately $47.8M. The properties consist of two industrial buildings containing approximately 119,000 square feet on 2.7 acres in the Dogpatch submarket of San Francisco's Central Waterfront. The properties are at 1501 Tennessee Street and 1400 Minnesota Street, provide 12 dock-high and 15 grade-level loading positions and parking for 12 cars. The properties are 100% leased to nine tenants, two of which expire within one year and all of which expire by January 2024. The estimated stabilized cap rate of the property is 4.0%.
|
IDCC | Hot Stocks09:18 EDT InterDigital increases stock repurchase program by $100M - InterDigital announced that the company's board has authorized a $100M increase to the company's existing stock repurchase program. The board authorized a $300M stock repurchase program in June 2014, which was increased to $400M in June 2015, to $500M in September 2017 and then to $600M in December 2018. The latest increase brings the total authorization to $700M.
|
C | Hot Stocks09:18 EDT Citi CEO says digital adoption increasing faster than peers
|
C | Hot Stocks09:16 EDT Citi CEO: Analyst revenue estimates lower than where Citi is
|
AMC | Hot Stocks09:15 EDT AMC Entertainment crosses 20M AMC Stubs households - AMC Entertainment announced that since the company relaunched its AMC Stubs program in summer of 2016, the program saw a 700% growth in membership in the U.S. "At the U.S. average of 2.6 people per household, that means more than 50 million people, which is more than 50 percent of the U.S. movie-going clientele, are enjoying the AMC experience through an engaged movie-going relationship via AMC Stubs."
|
FTR | Hot Stocks09:14 EDT Frontier to sell operations in Washington, Oregon, Idaho, Montana for $1.35B - Frontier Communications Corporation announced it has entered into a definitive agreement to sell its operations and all associated assets in Washington, Oregon, Idaho, and Montana to WaveDivision Capital in partnership with Searchlight Capital Partners for $1.352B in cash subject to certain closing adjustments. Frontier's operations in these states serve more than 350,000 residential and commercial customers as of March 31, 2019 and account for $619M of revenue, $46M of net income and $272M of Adjusted EBITDA1 for the twelve months ending March 31, 2019. The transaction is subject to regulatory approvals and other customary closing conditions, with closing anticipated to occur within one year. Frontier will continue to operate the business and serve customers with existing products and services until the transaction closes. WDC and Searchlight have formed a new company to operate the business and honor existing customer commitments and contracts after the transaction closes. Under the terms of the transaction, Frontier will receive $1.352B in cash at closing subject to certain adjustments, including working capital as compared to an agreed target, and certain pension and retiree medical liabilities. Frontier has also agreed to provide certain transition services to the new ownership group following the closing. The transaction is subject to regulatory approvals by the Federal Communications Commission, the U.S. Department of Justice, the Committee on Foreign Investment in the United States, applicable state regulatory agencies, and certain local video franchise authorities.
|
NITE BIIB | Hot Stocks09:13 EDT Nightstar Therapeutics updates timetable relating to Biogen acquisition - Nightstar Therapeutics (NITE) announced an update to the expected timetable of events relating to the scheme of arrangement pursuant to which Tungsten, a newly-incorporated company and wholly-owned indirect subsidiary of Biogen (BIIB), will acquire the entire issued and to be issued share capital of Nightstar. The scheme remains subject to certain conditions including sanction by the court at the court hearing, which will now take place on June 5 and the delivery of a copy of the court order to the Registrar of Companies. Subject to the scheme receiving the sanction of the court and the delivery of a copy of the court order to the Registrar of Companies, the acheme is still expected to become effective on June 7.
|
SAIL | Hot Stocks09:10 EDT SailPoint receives initial approval for AI, machine learning application patent - SailPoint Technologies has received initial approval for a new U.S. patent, covering SailPoint's application of Artificial Intelligence and Machine Learning to peer group analysis. The pending patent is titled "System and Method for Peer Group Detection, Visualization and Analysis in Identity Management Artificial Intelligence Systems Using Cluster-Based Analysis of Network Identity Graphs." AI and ML, when applied to identity data, speeds the discovery, visualization and analysis of peer groups, delivering highly-accurate, relevant and scalable results. The patent-pending technology is a key component of SailPoint Predictive Identity, the intelligent cloud identity platform of the future.
|
KTOS | Hot Stocks09:09 EDT Kratos Defense receives $5M C5ISR production award from government agency - Kratos Defense announced that it has recently received a $5M command, control, communication, computing, combat and intelligence, surveillance and reconnaissance, or C5ISR, production award from a U.S. government agency. Kratos C5ISR modular systems business provides products, hardware and solutions to the U.S. Department of Defense and other national security customers. Work under this recent contract award will be performed in a secure Kratos manufacturing facility. Due to customer related, competitive and other considerations, no additional information will be provided related to this contract award.
|
HPP | Hot Stocks09:07 EDT Hudson Pacific to develop office tower at WSCC Addition - Hudson Pacific Properties announced that the company has purchased the condominium rights to build a fully entitled office development adjacent to the 1.5 million-square-foot Washington State Convention Center Addition for $86M before credits, prorations and closing costs. The planned approximately 538,000-square-foot office tower will be centrally located at the intersection of Boren Avenue and Olive Way in Seattle's booming Denny Triangle neighborhood. The 1.17-acre, full-block site is fully entitled for a 16-story office tower due to extensive predevelopment and design work by the WSCC Addition's development team, including Pine Street Group as pre-development manager and LMN as architect. Targeting LEED Gold, the tower will have approximately 526,000 square feet of office space and 12,000 square feet of retail. Hudson Pacific estimates total development costs, including the purchase price, in the range of $300-350 million. Hudson Pacific expects to commence construction as early as mid-2021 with delivery for tenant improvements in late 2022.
|
C | Hot Stocks09:07 EDT Citi CEO says trade, Iran, Brexit weighing on market - Citi CEO Michael Corbat said the biggest recession risk is "talking ourselves into it." Says Argentina business doing better than ever. Comments taken from Bernstein's 35th Annual Strategic Decisions Conference.
|
BBY | Hot Stocks09:06 EDT Best Buy to sell AliveCor's KardiaMobile in stores nationwide - Best Buy and AliveCor, owner of FDA-cleared consumer electrocardiogram technology, announced a strategic partnership, bringing AliveCor's products to select Best Buy stores across the country. KardiaMobile is now available at most Best Buy stores.
|
NMRD | Hot Stocks09:04 EDT Nemaura Medical receives CE Mark approval for SugarBEAT - Nemaura Medical announced that it has received CE Mark approval for SugarBEAT. With this approval, Nemaura is permitted to commence sales of SugarBEAT throughout the European Union. The CE Mark approval includes recently added predictive alerts to the product design, which provide visual indication when glucose levels are falling or rising above minimum and maximum thresholds. Additional audible alerts or physical vibration of the bluetooth-enabled mobile phone connected to SugarBEAT occur in instances where glucose levels are deemed to fall to dangerously low levels, until switched off by the user.
|
IP | Hot Stocks09:03 EDT International Paper to sell India-based paper business to West Coast Paper Mills - International Paper has entered into an agreement with West Coast Paper Mills to sell its controlling interest in International Paper APPM Limited, an India-based paper business. International Paper currently owns approximately 30M shares, or 75% of the outstanding shares, of International Paper APPM Limited. The transaction is expected to be completed by the end of the year subject to satisfaction of customary closing conditions, including obtaining required governmental approvals and West Coast Paper Mills Limited's launch of a tender offer. Pursuant to Indian securities law requirements, WCPM will launch a tender offer to acquire up to all of the APPM shares owned by public shareholders, which represents 25% of APPM's outstanding shares. The closing of IP's transaction with WCPM will occur following the completion of the tender offer and receipt of antitrust clearance. Depending on the results of that tender offer, WCPM will acquire from IP between 51% and 60% of the outstanding APPM shares at a price per share of 275 Indian Rupees. Once this transaction closes, WCPM will be responsible for the operations of APPM, and International Paper will be a passive investor until such time that IP has sold its remaining shares in APPM.
|
CARA... | Hot Stocks08:55 EDT Fly Intel: Pre-market Movers - HIGHER: Cara Therapeutics (CARA), up 14% after announcing topline data from the KALM-1 pivotal Phase 3 trial of Korsuva Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus... Soliton (SOLY), up 45% after deciding to move forward with a pivotal trial in cellulite after data from its proof of concept clinical trial for the reduction of cellulite was confirmed. UP AFTER EARNINGS: Dick's Sporting (DKS), up 2%. DOWN AFTER EARNINGS: Capri Holdings (CPRI), down 6%... Canada Goose (GOOS), down 15%... Abercrombie & Fitch (ANF), down 17%. LOWER: Boeing (BA), down 1% after The Wall Street Journal reports IATA Director General Alexandre de Juniac said airlines are preparing for 10-12 more weeks of delay before the Boeing 737 MAX can return to service... ArcelorMittal (MT), down 3% after announcing its decision to take additional steps to cut its European production levels to further align its production to the current market demand.
|
BA | Hot Stocks08:52 EDT Boeing says 'very engaged' in U.S-China trade talks - Says: U.S-China agree on need for healthy aerospace industry... Prospects in China "very strong"... Sees $40B-$60B commercial opportunities from T-X, MQ-25...Continues to see strong opportunities across the globe... Expects International segment to outpace domestic near term... Won't reinstate guidance until 737 MAX is flying... "Laser focused" on 737 MAX return... Long term prospects for company's product lines "remain solid." Comments from Bernstein Strategic Decisions Conference.
|
NXPI MRVL | Hot Stocks08:48 EDT NXP Semiconductors to acquire Marvell's $1.76B wireless connectivity portfolio - NXP Semiconductors (NXPI) announced that its wholly owned subsidiary has entered into a definitive agreement with Marvell (MRVL) under which NXP will acquire Marvell's wireless connectivity portfolio in an all-cash, asset transaction valued at $1.76B. The acquisition encompasses Marvell's wifi connectivity business unit, bluetooth technology portfolio and related assets. The acquisition will enable NXP to deliver processing and connectivity solutions to its customers across its focus end markets. The acquisition includes approximately 550 people worldwide. NXP expects the acquisition to create new revenue opportunities in its target end markets. With approximately $300M in revenue in Marvell's FY19, NXP anticipates revenue associated with the acquired assets to double by 2022. The acquisition is expected to be accretive to NXPs non-GAAP operating profit in the first full quarter after the transaction closes. The transaction is expected to close by Q1 of 2020, subject to customary closing conditions, including regulatory approvals.
|
REZI | Hot Stocks08:44 EDT Whisker Labs sells energy managment business to Resideo, terms not disclosed - Outcome Capital announced that Whisker Labs has sold its Energy Management business to Resideo Technologies. Outcome Capital provided exclusive advisory services to the Company. Based in Germantown, MD, Whisker Labs develops sensing and software technology for home intelligence. The Company's energy management platform applies machine learning to reduce electricity demand during peak load times and to optimize thermostats for savings and comfort. The platform creates a thermodynamic model of a home as well as integrates with market-leading thermostat products to predict and optimize the energy used by residential HVAC systems. Whisker Labs manages over 100,000 thermostats across the United States, enabling retail energy providers to optimize procurement strategies, increase margins, and offer cost savings to their customers. The transaction expands Resideo's smart-home comfort offering while helping Whisker Labs focus on the development of Ting, its electrical fire-sensing technology.
|
ALTM KMI | Hot Stocks08:42 EDT Altus Midstream acquires 26.7% equity interest in Permian Highway Pipeline - Altus Midstream (ALTM) announced that its subsidiary, Altus Midstream Processing, has exercised and closed its option to acquire an approximate 26.7% equity interest in the Permian Highway Pipeline, or PHP. PHP is an estimated $2.1B long-haul pipeline that is expected to have approximately 2.1 Bcf/d of natural gas transportation capacity from the Waha area in northern Pecos County, Texas, to the Katy, Texas area, with connections to Texas Gulf Coast and other markets. The final investment decision to proceed with the project was made in September 2018, and the initial capacity of the pipeline is fully subscribed under long-term binding agreements. PHP is expected to enter service in October 2020 and is approximately 26.7% owned by each of Altus Midstream Processing, Kinder Morgan (KMI) and EagleClaw Midstream Ventures with the remaining 20% owned by an anchor shipper affiliate.
|
NXPI MRVL | Hot Stocks08:42 EDT NXP Semiconductors expects Marvell deal to be accretive in first full quarter - NXP Semiconductors (NXPI) says the acquisition of Marvell's (MRVL) Wireless Connectivity "will enable NXP to deliver complete, scalable processing and connectivity solutions to its customers across its focus end markets. NXP expects the acquisition to create new revenue opportunities in its target end markets. With approximately $300M in revenue in Marvell's fiscal 2019, NXP anticipates revenue associated with the acquired assets to double by 2022. The acquisition is expected to be accretive to NXPs non-GAAP operating profit in the first full quarter after the transaction closes."
|
ITCB | Hot Stocks08:40 EDT Itau Corpbanca announces acquisition of Corredores de Bolsa - Itau Corpbanca announced that it filed a material event notice reporting the acquisition of Corredores de Bolsa in compliance with the transaction agreement with the Chilean Financial Market Commission and with the Chilean Superintendency of Banks and Financial Institutions.
|
AITB | Hot Stocks08:37 EDT AIT Therapeutics announces Cystic Fibrosis study published - AIT Therapeutics announced a study was published in the Journal of Cystic Fibrosis. The open-label pilot study assessed the safety and efficacy of intermittent inhaled NO, or iNO, as an adjuvant therapy to antibiotics in nine cystic fibrosis patients with refractory M. abscessus lung infection. Subjects received 160ppm iNO five times per day during hospitalization and three times per day during ambulatory treatment for a total of 21 days of treatment. The primary outcome of safety was measured by NO-related serious adverse events, or SAEs; secondary outcomes were six-minute walk distance,or 6MWD, forced expiratory volume in 1 second, or FEV1 and M. abscessus burden in airways. Results showed iNO was well-tolerated and no iNO-related SAEs were observed during the study. Mean FEV1 and 6WMD increased relative to baseline during NO treatment. M. abscessus culture conversion was not achieved, but three of the nine patients experienced at least one negative culture during the study. Mean time to positivity in M. abscessus culture, and qPCR analysis showed reductions in sputum bacterial load. The study was not powered to achieve statistical significance in FEV1, 6WMD, or bacterial load.
|
ONCS | Hot Stocks08:36 EDT OncoSec collaborating for Tavo in Australia with Emerge Health - OncoSec and Emerge Health Pty, an Australian company providing full registration, reimbursement, sales, marketing and distribution services of therapeutic products in Australia and New Zealand, have entered into a collaboration agreement commercializing OncoSec's proprietary Tavo and making it available under Australia's Special Access Scheme in 2019. This collaboration will allow OncoSec to begin generating revenue, potentially as early as Q4. Tavo will be the only drug available under the SAS program for melanoma patients who have failed checkpoint inhibitor or targeted therapy.
|
BA ERJ | Hot Stocks08:33 EDT Boeing says plans to tailor 737 MAX deliveries to customer fleet plans - Says: Plans to reorder deliveries on 737 MAX once grounding lifts... Boeing (BA) board committee studying improvements in certification... Sees 787-9, 787-10 driving higher program margins... Still at "early stages" of 787 Dreamliner production... Exploring additional targeted automation for 787... Third and fourth 777X are in final assembly... 777X progressing to plan, expects 2020 market debut... Plans to roll 737 MAX learnings in 777X certification... Doesn't see 777X certification changes affecting debut... Still targeting 2025 debut for new mid-range jetliner... Still plans to eventually ramp 737 MAX output to 57 per month... R&D and innovation still will be number one use of cash... Seeking "select investments" for future single-aisle jet... On track to close on Embraer (ERJ) deal by end of 2019... Sees services as a "growth business"... Scouting " bolt-on" services acquisitions like KLX deal. Comments from Bernstein Strategic Decisions Conference.
|
RWLK | Hot Stocks08:33 EDT ReWalk Robotics receives CE mark for ReStore stroke rehabilitation device - ReWalk Robotics' ReStore Exo-Suit for stroke rehabilitation has received CE marking, clearing it for sale to rehabilitation clinics in the European Union. This CE Mark is the first clearance of a soft exo-suit, a next generation medical device which can serve a larger and more diverse patient population facing mobility challenges. ReStore will be priced lower than the first generation of rigid exoskeleton technologies. ReWalk will offer direct purchase and third party leasing programs for the ReStore in the EU.
|
MRVL NXPI | Hot Stocks08:33 EDT Marvell's Wi-Fi Connectivity business to be acquired by NXP for $1.76B in cash - Marvell (MRVL) announced that it has entered into a definitive agreement under which NXP (NXPI) will acquire Marvell's Wi-Fi Connectivity business in an all-cash, asset transaction valued at $1.76B. The business employs approximately 550 people worldwide and generated roughly $300M in revenue in Marvell's FY19. This transaction has been approved by the boards of directors of NXP and Marvell and is expected to close by calendar Q1 2020. Marvell anticipates that this divestiture will enhance its gross and operating margins upon closing.
|
GILD | Hot Stocks08:32 EDT Gilead appoints Johanna Mercier as Chief Commercial Officer - Gilead Sciences (GILD) announced that Johanna Mercier will join the company as Chief Commercial Officer and will become a member of the company's senior leadership team. Mercier will assume responsibility for the company's commercial operations effective July 1. Laura Hamill, Executive Vice President Worldwide Commercial Operations, will be departing from Gilead. She joins Gilead from Bristol-Myers Squibb (BMY), where she most recently served as President and Head of the company's Large Markets division, which includes the United States, France, Germany and Japan.
|
ANF | Hot Stocks08:20 EDT Abercrombie & Fitch plans to close three additional flagship stores - Says started Q1 with 861 stores and ended Q1 with 857 stores. Says expects changes in foreign currencies to have $30M adverse impact to net sales in FY19. Says focused on transformation initiatives with global store network optimization a key priority. Says remains on track to achieve FY19 outlook. Comments taken from Q1 earnings presentation.
|
QADB | Hot Stocks08:17 EDT QAD Inc expands partnership with Scott Sheldon LLC - QAD Inc. has entered into a channel partnership that affords Scott Sheldon LLC the ability to resell QAD Adaptive Applications in North America. QAD began working with Scott Sheldon in 2016, signing a consultancy partnership agreement in North America, giving Scott Sheldon the right to provide services in relation to QAD's enterprise and supply chain software.
|
ALNY ABMD | Hot Stocks08:15 EDT Alnylam appoints Kevin Fitzgerald as CSO, Kelley Boucher as CHRO - Alnylam Pharmaceuticals announced the appointment of Kelley Boucher as the company's SVP, Chief Human Resources Officer and the promotion of Kevin Fitzgerald, Ph.D., as SVP, Chief Scientific Officer. In the role, Boucher will help guide organizational design and development, talent management, team effectiveness, culture, change management, and strategic talent acquisition - all while ensuring that Alnylam culture and philosophy are scalable and permeate the Company's 26 current offices across 18 countries around the world. Most recently, Boucher was the VP and Head of Global Human Resources for Abiomed (ABMD). In his role, Fitzgerald will be responsible for the strategic direction and oversight of Alnylam's discovery engine. Fitzgerald's tenure at Alnylam began in 2005 when he joined as an Associate Director of Research. He has headed the Research department since 2016.
|
FCSC | Hot Stocks08:13 EDT Fibrocell Science granted RMAT designation from FDA for FCX-007 - Fibrocell Science announced that the FDA has granted the regenerative medicine advanced therapy, or RMAT, designation to FCX-007, the company's gene therapy candidate for the treatment of recessive dystrophic epidermolysis bullosa, or RDEB, a genetic skin disease with high mortality. The company expects to initiate the Phase 3 clinical trial for FCX-007 in Q2. Fibrocell projects enrollment and dosing of Phase 3 patients will be completed in Q3of 2020 and data collection for the primary endpoint will be completed in Q4 of 2020.
|
GOGO | Hot Stocks08:12 EDT Gogo to launch 5G network for aviation in 2021 - Gogo plans to build a 5G network for aviation. The new air-to-ground network will be designed for use on business aviation aircraft, commercial regional jets and smaller mainline jets operating within the contiguous United States and Canada. Gogo expects the network to be available for business and commercial aviation in 2021.
|
HOLX | Hot Stocks08:12 EDT Hologic announces FDA clearance for Aptima BV, Aptima CV/TV assays - Hologic announced that the FDA has granted clearance for its new Aptima BV and Aptima CV/TV assays, which provide an accurate and objective method for diagnosing vaginitis, "a very common and complex health issue affecting millions of women each year... Unfortunately, many women self-diagnose and self-treat before visiting a healthcare provider, assuming that abnormal vaginal discharge, itching or irritation is due to a simple yeast infection... The Aptima Multitest Swab Specimen Collection Kit enables healthcare providers to test up to seven disease states and infections, including BV, Candida species, Candida glabrata, trichomoniasis, chlamydia, gonorrhea and Mycoplasma genitalium."
|
VXRT | Hot Stocks08:12 EDT Vaxart announces publication highlighting results of chikungunya vaccine - Vaxart announced the publication of the comprehensive results from a preclinical trial of its chikungunya vaccine in the peer reviewed journal, Vaccine. The article, titled "An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling," details the results from a study using Vaxart's chikungunya vaccine candidate in a preclinical efficacy model. Vaxart develops oral vaccines for a broad range of infections that have a major impact on public health, including vaccines for norovirus and influenza.
|
SOLY | Hot Stocks08:11 EDT Soliton to begin cellulite reduction trial after proof-of-concept results - Soliton has decided to move forward with a pivotal trial in cellulite after positive data from its proof of concept clinical trial for the reduction of cellulite confirmed. The Pivotal cellulite study is expected to begin within the next three months. In a single 20-minute, non-invasive treatment, the Rapid Acoustic Pulse device was applied to the surface of the patients' skin. The treatments required no anesthesia, caused no bruising, swelling or bleeding, and were evaluated as relatively painless by the trial participants, none of whom experienced any post-treatment discomfort or downtime. While the company's RAP device intended to assist in tattoo removal was recently cleared by the FDA, this higher-powered version will require a new application for clearance for the cellulite indication. In the POC Trial, approximately 97% of treatments were rated 0 on a 0 to 10-point pain scale. At the end of the 12-week POC Trial, 100% of the patients showed clinical improvement. The range of improvement in cellulite severity score was 20% to 47% and the average improvement for all patients was nearly a 30% improvement. The only FDA approved method for long-term reduction of cellulite is an invasive treatment requiring topical anesthesia, penetration of the skin and involves potential bleeding, bruising and significant post-treatment discomfort and downtime.
|
IOVA | Hot Stocks08:10 EDT Iovance Biotherapeutics to build production facility in Philadelphia - Iovance Biotherapeutics announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility in Philadelphia for commercial and clinical production of autologous TIL products, including its candidate lifileucel. The facility will allow production according to FDA guidelines and is designed to provide scalability using modular processes. The facility will be designed and built for a maximum capacity to manufacture TIL products for several thousands of patients annually. The lease agreement and construction of the new Iovance facility at the Navy Yard is expected to create employment opportunities for several hundred individuals in Philadelphia once at full capacity. Iovance expects to invest approximately $75M over three years for equipment and construction of the manufacturing suites. The facility is expected to be completed in approximately two years.
|
HZNP NVTA | Hot Stocks08:10 EDT Horizon Pharma, Invitae announce new UCD genetic testing program - Horizon Therapeutics plc (HZNP) in partnership with Invitae Corporation (NVTA) announced a new urea cycle disorder genetic testing program designed to speed diagnosis and enable physicians to offer genetic testing at no-charge to people who may have a UCD, including their family members. Horizon's support of the UCD Genetic Testing Program facilitates the genetic tests and services offered and performed by Invitae. The UCD Genetic Testing Program utilizes the Invitae Hyperammonemia Panel to evaluate 58 genes that are associated with the enzymes and transporter proteins responsible for the production and detoxification of ammonia. Horizon provides financial support to Invitae for this program, which enables physicians to offer genetic testing at no-charge to their patients. Patient privacy is strictly protected and Horizon does not have any access to any identifiable patient information. Tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Genetic testing and counseling are only available in the United States.
|
BA | Hot Stocks08:09 EDT Boeing says returning 737 MAX to service is number one focus - Says: In process of applying for final software certification... Making "clear and steady progress" on 737 MAX... Sees "solid" aerospace market long term.... Backlog continues to be at or near record levels... Confident we will come out stronger as a company when 737 MAX issue is is resolved... FAA's May 23 summit set "generally positive tone"... Need to ensure supply chain is stable before ramping 737 MAX... Deploying field service teams to each stored 737 MAX. Comments from Bernstein Strategic Decisions Conference.
|
INT | Hot Stocks08:09 EDT World Fuel Services raises quarterly dividend to 10c per share - World Fuel Services announced that its board has declared the company's quarterly cash dividend which, as previously announced, has been increased to 10c per share and will be payable on July 5, to shareholders of record on June 10.
|
INT | Hot Stocks08:08 EDT World Fuel Services increases share repurchase program to about $150M - World Fuel Services announced that its board has approved a $100M increase to the company's share repurchase program announced in October 2017, increasing the available authorization remaining under the program to approximately $150M.
|
NVIV | Hot Stocks08:06 EDT InVivo Therapeutics enrolls first 2 patients into INSPIRE 2.0 study - InVivo Therapeutics announced that the first two patients have been enrolled into The INSPIRE 2.0 Study, or InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. The INSPIRE 2.0 Study is a two-arm 20-patient--10 subjects in each study arm--randomized, controlled trial designed to provide clinical data that will supplement the existing clinical results from the company's previous single-arm study. The definition of study success for the INSPIRE 2.0 Study is that the difference in the proportion of subjects who demonstrate an improvement of at least one grade on ASIA Impairment Scale assessment at the six-month primary endpoint follow-up visit between the Scaffold Arm and the Comparator Arm must be equal to or greater than 20%.
|
PRU | Hot Stocks08:06 EDT Aker Solutions, Reser's Fine Foods choose Prudential for retirement assets - Aker Solutions and Reser's Fine Foods chose Prudential Retirement as record keeper for their defined contribution retirement plans. Prudential Retirement is a business unit of Prudential Financial. With $142M in retirement assets, Aker Solutions' plan has 1,273 participants and transitioned on March 1, 2019. Reser's Fine Foods Inc.'s plan transitioned on April 18, 2019.
|
CLI | Hot Stocks08:05 EDT Mack-Cali Realty to form committee for review of 'strategic direction' - Mack-Cali Realty announced that its board intends to form a committee of independent directors to conduct a review of the company's strategy, asset portfolio and business opportunities to ensure that all available alternatives for continuing stockholder value creation are carefully and thoughtfully considered. The board expects to form the Strategic Review Committee after its upcoming Annual Meeting of Stockholders scheduled for June 12, 2019. Upon completion of its review, the Strategic Review Committee will make a recommendation to the full board as to whether it is advisable to continue to execute on the company's business plan, consider a sale of the company or any of its assets, or take other action to maximize stockholder value. The company also agreed to establish a committee of independent directors, which would include the two Bow Street nominated directors, to conduct a review of the company's strategic direction. However, despite the company's good faith efforts to negotiate a fair and reasonable settlement, the parties were unable to reach an agreement due to fundamental differences as to the committee's objectives and process, including Bow Street's desire to force a precipitous sale of the company at any price, which would allow Bow Street to realize a quick profit on its recent investment, but would be detrimental to other Mack-Cali stockholders. Bow Street was also unwilling to agree to a meaningful standstill and demanded expense reimbursement of up to $2.0M, which the company believes is vastly in excess of any reasonable amount.
|
OCUL | Hot Stocks08:05 EDT Ocular Therapeutix receive C-code, pass-through payment status for Dextenza - Ocular Therapeutix announced that the Centers for Medicare and Medicaid Services, or CMS, has approved transitional pass-through payment status and established a new reimbursement code for Dextenza. The code, C9048, is scheduled to become effective July 1.
|
GLUU WWE | Hot Stocks08:04 EDT Glu, WWE launche WWE Universe - Glu Mobile (GLUU) announced the availability of WWE Universe on the App Store and Google Play. As part of a multi-year agreement with WWE (WWE), and developed by the same studio as Glu's largest sports franchise, Tap Sports Baseball, WWE Universe offers the most authentic WWE experience on mobile to date, allowing players to build and train dream rosters before challenging others.
|
SPAR | Hot Stocks08:03 EDT Spartan Motors granted vehicle assembly contract with Grande West Transportation - Spartan Motors business unit Spartan Specialty Chassis and Vehicles has entered into an exclusive U.S.-based assembly agreement with Grande West Transportation, a Canadian bus manufacturer that designs, engineers, and manufactures purpose-built mid-size buses for transit authorities and commercial enterprises. Spartan will manufacture Grande West's Vicinity model buses, which will continue to satisfy the Federal Transit Administration's Buy America requirements and reduce potential tariff exposures.
|
MDWD | Hot Stocks07:55 EDT MediWound announces additional $21M in funding from BARDA - MediWound announced that the U.S. Biomedical Advanced Research and Development Authority, or BARDA, has upsized its awarded contract with MediWound and provided supplemental funding of $21M to initiate NexoBrid expanded access treatment protocol, or NEXT. Under the modified contract including this supplemental amount, BARDA will provide technical assistance and a total amount of $77M in funding for NexoBrid development activities towards U.S. marketing approval from the FDA. These activities include the ongoing NexoBrid Phase 3 study and subsequent requirements for biologics license application, or BLA, submission, the ongoing Phase 3 pediatric study and now also the new NexoBrid expanded access treatment protocol. The modified contract maintains the $16.5M commitment for procurement of NexoBrid, contingent upon FDA eligibility for use in an emergency or marketing approval; a $10M option to fund development of other potential NexoBrid indications and an option to fund up to $50M for additional NexoBrid procurement. In addition to this modified contract with MediWound for treatment of thermal burn injuries, BARDA also has a separate independent contract with MediWound to support the development of NexoBrid as a debridement product to treat sulfur mustard injuries, providing $12M in funding to support research and development activities up to pivotal studies in animals with options for additional funding of up to $31M for additional development activities through BLA submission. As a result of the additional $21M in committed funds for the thermal burn contract, the total non-dilutive funding under both contracts with BARDA is now valued at up to $196M. As of March 31, the company has received approximately $31M from BARDA.
|
JEC | Hot Stocks07:47 EDT Jacobs Engineering awarded four-year site restoration contract in Scotland - Jacobs has been awarded a four-year framework agreement by Dounreay Site Restoration to provide decommissioning services. Located in Caithness County, Scotland, the Dounreay site is one of the most complex nuclear decommissioning programs in Europe, with extensive remediation activities underway to return the former nuclear energy testing site to as near its original condition as possible. DSRL estimates that the decommissioning services framework is worth up to $500M. The framework, spanning four years with potential extensions of up to three years, has been awarded to six organisations.
|
RYB | Hot Stocks07:43 EDT RYB Education appoints Hao Gu as CFO - RYB Education has appointed Hao Gu as its CFO, effective June 1. Gu will succeed Ping Wei, who has decided to retire from the role of CFO which she took in 2017. Wei will continue to serve RYB as a senior advisor. Prior to joining RYB, Gu worked as an executive director of the Asia Pacific Telecom, Media and Technology team in UBS AG's Investment Banking Division in Hong Kong.
|
DKS | Hot Stocks07:38 EDT Dick's Sporting up 6.3% to $38.02 after Q1 results beat estimates - The company also raised its FY19 profit oultook.
|
DKS | Hot Stocks07:35 EDT Dick's Sporting CEO says 'we were pleased with our start to 2019' - "We were pleased with our start to 2019, delivering higher merchandise margins and first quarter earnings per diluted share above last year. Same store sales turned positive in March and remained positive in April, as we started to see the benefits of our key strategies and investments," said Edward Stack, Chairman and CEO. "We are very enthusiastic about our business and are pleased to increase our full year earnings outlook." "During the first quarter, we made great progress in executing against our strategic priorities and investments as we remain focused on improving the in-store and online experience for our athletes and driving productivity improvements across our business," added Lauren Hobart, President. "As we continue to build the best omni-channel experience in sporting goods, we see significant opportunity to drive competitive advantage in the marketplace and strengthen our leadership position."
|
DKS | Hot Stocks07:34 EDT Dick's Sporting reports Q1 ecommerce sales up 15% - eCommerce sales for the first quarter increased 15%. eCommerce penetration for the first quarter was approximately 13% of total net sales, compared to approximately 11% during the first quarter of 2018.
|
DKS | Hot Stocks07:33 EDT Dick's Sporting expects to open seven new DICK'S Sporting Goods stores in 2019 - The company expects to open seven new DICK'S Sporting Goods stores and relocate three DICK'S Sporting Goods stores in 2019. The company also expects to open two new Golf Galaxy stores and relocate one Golf Galaxy store in 2019. Six of the new stores are expected to open during the third quarter. In 2019, the company anticipates capital expenditures to be approximately $230M on a gross basis and approximately $200M on a net basis. In 2018, capital expenditures were $198M on a gross basis and $170M on a net basis.
|
DKS | Hot Stocks07:30 EDT Dick's Sporting reports Q1 SSS flat
|
RMCF | Hot Stocks07:30 EDT Rocky Mountain Chocolate trading resumes
|
CARA | Hot Stocks07:30 EDT Cara Therapeutics trading resumes
|
ELY | Hot Stocks07:21 EDT Callaway Golf says in talks to acquire remaining stake in Callaway Apparel JV - In a regulatory filing, Callaway Golf Company reported that it is currently engaged in discussions, through its Japanese subsidiary Callaway Golf K.K., to acquire from TSI Groove & Sports Co. Ltd. the remaining stake in Callaway Apparel K.K., the company's apparel joint venture in Japan between CGKK and TSI. Currently, CGKK owns 52% of CAKK and TSI owns the remaining 48%.
|
BBBY | Hot Stocks07:19 EDT Bed Bath & Beyond says investor group withdraws board nominees - In connection with the appointments of the four new independent directors, Bed Bath & Beyond said it has entered into a cooperation and support agreement with the Investor Group, which together owns approximately 5.23% of the company's outstanding common stock. Under the terms of the agreement, the Investor Group has agreed to withdraw its slate of ten nominees and support and vote in favor of all of the Bed Bath & Beyond-recommended director nominees at the 2019 and 2020 Annual Meetings of Shareholders, which will include the four new independent directors appointed today. The Investor Group also has agreed to abide by certain customary standstill provisions until 30 days prior to the close of the nomination window for the company's 2021 Annual Meeting of Shareholders. The litigation filed by a member of the Investor Group is also being withdrawn and dismissed.
|
CARA | Hot Stocks07:17 EDT Cara Therapeutics announces topline data from KALM-1 Phase 3 trial - Cara Therapeutics announced topline data from the KALM-1 pivotal Phase 3 trial of Korsuva Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus, or CKD-aP. The proportion of patients on 0.5 mcg/kg of Korsuva Injection achieving a three-point or greater improvement from baseline in the weekly mean of the daily 24 hour Worst Itching Intensity Numeric Rating Scale, or WI-NRS, score at week 12 was 51% vs. 28% for patients on placebo. The proportion of patients on 0.5 mcg/kg of Korsuva Injection achieving a four-point or greater improvement from baseline in the weekly mean of the daily 24 hour WI-NRS score at week 12 was 39% vs. 18% for patients on placebo. Patients on Korsuva Injection experienced a 43% improvement in the average total Skindex-10 score at week 12 vs. patients on placebo. Patients on Korsuva Injection experienced a 35% improvement in the average total 5-D Itch score at week 12 vs. patients on placebo. Korsuva was generally well-tolerated with a safety profile consistent with that seen in earlier Korsuva clinical trials. Overall, the incidence of adverse events, or AEs, and serious AEs were similar across both Korsuva and placebo groups. The most common treatment emergent AEs reported in greater than 5% of patients were diarrhea, dizziness, nasopharyngitis and vomiting.
|
ARVN | Hot Stocks07:11 EDT Arvinas announces fast track designation for ARV-110 - Arvinas announced that its lead Protac protein degrader, ARV-110, has been granted fast track designation by the FDA for the treatment of men with metastatic castration-resistant prostate cancer, or mCRPC, whose disease has progressed after treatment with two or more systemic therapies. ARV-110 is an orally bioavailable Protac protein degrader designed to selectively target and degrade the androgen receptor protein. ARV-110 is currently being evaluated in a Phase 1 clinical trial designed to evaluate the safety, tolerability, and pharmacokinetics of ARV-110 in men with mCRPC whose disease has progressed after treatment with standard of care therapies.
|
HLNE | Hot Stocks07:07 EDT Hamilton Lane increases quarterly dividend 29% to 27.5c per share - Hamilton Lane declared a quarterly dividend of 27.5c per share of Class A common stock to record holders at the close of business on June 14 that will be paid on July 5. This represents a 29% increase from the prior dividend.
|
CLI | Hot Stocks07:06 EDT Bow Street urges Mack-Cali Realty shareholders to vote for director nominees - Bow Street, a New York-based investment firm that beneficially owns approximately 4.5% of the outstanding shares of common stock of Mack-Cali Realty Corporation, is sending a letter to Mack-Cali shareholders. The letter read, in part, "As shareholders of Mack-Cali Realty Corporation, we have trusted its long-tenured Board of Directors to steward our capital. However, this Board has failed us. Since taking over as Chairman in 2000, and particularly over the past 15 years, William Mack has overseen strategies that have resulted in a ~70% decrease in dividends and a ~50% share price decline1. Over this period, debt has increased from ~4.5x Debt/EBITDA2 to over 9x Debt/EBITDA3, reducing Mack-Cali's financial flexibility and leaving our Company lacking any credible standalone path to the creation of durable shareholder value. Even over the last several weeks, when presented with credible third-party proposals to acquire all or meaningful portions of Mack-Cali for all-cash consideration, the Board explicitly discouraged suitors, once again thwarting opportunities to create shareholder value. We have repeatedly called on the Board to establish a truly independent committee tasked with evaluating all strategic alternatives for Mack-Cali, including whether and how to pursue a sale of the Company. In response, the Board proposed "window dressing" - a toothless strategic review committee staffed by directors loyal to Chairman Mack, expressly prohibited from speaking with prospective acquirers or consulting an investment bank. Such a committee lacks both the tools and mandate to create value for Mack-Cali shareholders; its only purpose would be to perpetuate and legitimize the broken status quo. As the owners of Mack-Cali, we deserve better. We deserve directors who will work to create value for ALL shareholders. We deserve directors who will explore ALL meaningful solutions to address the structural and governance issues that have plagued the Company for decades. This Board must be held accountable for its lack of oversight, broken promises and failed strategies. After decades of poor returns, shareholders finally have a choice...Bow Street's four independent director nominees - Alan Batkin, Frederic Cumenal, MaryAnne Gilmartin, and Nori Gerardo Lietz - are accomplished business leaders with deep board and governance experience, and real estate operations, development and investment expertise. If elected, Bow Street's nominees will be fierce advocates for all shareholders"
|
PJC | Hot Stocks07:05 EDT Tortoise to acquire Advisory Research midstream energy business from Piper - Tortoise announced it has reached a definitive agreement to acquire the midstream energy asset management business of Advisory Research from parent company Piper Jaffray. The Advisory Research midstream energy infrastructure team has approximately $3B in assets under management in both balanced and equity strategies, through mutual funds, sub-advised closed-end funds and separate accounts. The transaction brings together two highly experienced and tenured midstream energy pioneers with strong track records and complementary investment philosophies anchored in fundamental research. The Advisory Research midstream energy infrastructure team, including Senior Portfolio Managers Jim Cunnane, Jr. and Quinn Kiley, will join Tortoise. The existing team will maintain oversight of Advisory Research's current midstream energy infrastructure business and client relationships. The transaction is expected to close during the second half of 2019, subject to customary regulatory and closing conditions, including fund board/shareholder approval.
|
CSIQ | Hot Stocks07:02 EDT Canadian Solar signs record 1,800 MW module supply agreement with EDF Renewables - Canadian Solar has signed a multi-year module supply agreement with EDF Renewables North America to deliver 1,800 MW of poly solar modules for projects in the US, Canada, and Mexico. This module supply agreement is the largest single module supply agreement signed in Canadian Solar's 18-year history, and is an anchor of the company's 3+ GW of forward-committed contracts in the North American market through 2023.
|
REVG | Hot Stocks07:00 EDT REV Group's ambulance division awarded five-year contract by FDNY - REV Group's ambulance division was awarded a five-year contract to build up to 425 Type I Wheeled Coach ambulances for the Fire Department of New York. The contract calls for a variety of vehicle configurations that is valued at approximately $160M depending on the vehicle mix requirements. It is anticipated that ambulances related to this contract will begin to ship mid FY20. This new fleet of ambulances includes an auxiliary power unit to meet the FDNY Green initiative.
|
ACM | Hot Stocks06:58 EDT Aecom-led joint venture granted $107.4M design-build contract for New York City - Aecom's joint venture with Hill International has been awarded a contract valued at $107.4M by the New York City Department of Design and Construction for the Program Manager for development of four new correctional facilities. The new borough-based facilities will be located in Manhattan, Brooklyn, Queens and the Bronx and will enable the closure of the Rikers Island Correctional Facility. The value of AECOM's contract was included in its backlog in Q3.
|
PJC | Hot Stocks06:57 EDT Piper Jaffray announces sale of Advisory Research - Piper Jaffray announced the sale of Advisory Research through two separate transactions which will result in the firm exiting its traditional asset management business. It has signed a definitive agreement to sell the midstream energy business of Advisory Research to Tortoise Capital Advisors. Piper Jaffray has also entered into a letter of intent to sell the remaining Advisory Research business to a partner group led by Matthew Swaim, managing director and executive committee chairman at Advisory Research. Piper Jaffray expects to generate net cash proceeds from these two transactions of approximately $60M-70M, exclusive of potential earn-out proceeds. Advisory Research currently represents approximately 5% of Piper Jaffray's adjusted net revenue. The transactions are expected to close in the second half of 2019 and are subject to customary regulatory and closing conditions, including client consents. The earn-out provisions of the Tortoise transaction provide additional potential consideration based on year one results.
|
LCI JNJ | Hot Stocks06:56 EDT Lannett commences marketing generic Concerta - Lannett (LCI) announced that it has commenced marketing Methylphenidate Hydrochloride Extended Release, or ER, tablets USP in 18 mg, 27 mg, 36 mg and 54 mg strengths, an AB-rated generic equivalent to the brand Concerta. "Total U.S. sales of Methylphenidate Hydrochloride ER tablets were approximately $1.4B for the 12 months ended February 2019, according to IQVIA, although actual generic market values are expected to be lower." As previously announced, Lannett's strategic alliance partner, Andor Pharmaceuticals, recently received approval from the FDA of its Abbreviated New Drug Application of Methylphenidate Hydrochloride ER tablets USP in 18 mg, 27 mg, 36 mg and 54 mg strengths, the therapeutic equivalent to the reference listed drug, Concerta Extended-Release Tablets, 18 mg, 27 mg, 36 mg and 54 mg, of Janssen Pharmaceuticals (JNJ). Lannett entered into a licensing agreement with Andor for Methylphenidate Hydrochloride ER tablets, under which Lannett provides sales, marketing and distribution support of Andor's Methylphenidate ER product and receives a percentage of the net profits.
|
RMCF | Hot Stocks06:55 EDT Rocky Mountain Chocolate trading halted, news pending
|
CARA | Hot Stocks06:55 EDT Cara Therapeutics trading halted, news pending
|
RMTI | Hot Stocks06:52 EDT Rockwell Medical announces submission of NDA for I.V. Triferic - Rockwell Medical announced that it has completed the submission of its New Drug Application to the U.S. FDA for the Intravenous formulation of Triferic. Earlier this month, the company announced the launch of the first product from its portfolio, Dialysate Triferic. Dialysate Triferic is mixed with liquid bicarbonate to deliver iron to patients via the dialysate, while I.V. Triferic is designed to be administered to patients intravenously. As a result, if approved, I.V. Triferic would allow dialysis centers to administer Triferic to patients regardless of the mode of bicarbonate delivery being used.
|
ZYNE | Hot Stocks06:50 EDT Zynerba initiates Phase 2 trial of Zygel - Zynerba announced that it has initiated the Phase 2 INSPIRE trial. The INSPIRE trial will assess the safety, tolerability and efficacy of Zygel for the treatment of behavioral symptoms of 22q11.2 Deletion Syndrome. The company expects to present topline data from this study in the first half of 2020.
|
TPR VFC | Hot Stocks06:47 EDT Tapestry names Tom Glaser as COO, effective July 15 - Tapestry (TPR) announced the appointment of Thomas Glaser, as COO, effective July 15. Glaser will have responsibility across the end-to-end supply chain and the information technology backbone for Tapestry and its brands with functional oversight including product development and manufacturing resources, distribution, logistics, replenishment, ecommerce fulfillment and IT. He will report directly to the company's CEO, Victor Luis. Glaser joins Tapestry from VF Corporation (VFC), where he most recently held the position of Vice President, VF Corporation & President, Supply Chain.
|
CPRI | Hot Stocks06:45 EDT Capri Holdings down 10% to $35.00 after Q1, FY20 outlook miss estimates
|
CPRI | Hot Stocks06:44 EDT Capri Holdings down 10% to $35.00 after Q1, FY20 outlook misses estimates
|
FOLD | Hot Stocks06:41 EDT Amicus and University of Pennsylvania expand gene therapy collaboration - Amicus Therapeutics and the Perelman School of Medicine at the University of Pennsylvania announced a major expansion to their collaboration with rights to pursue collaborative research and development of novel gene therapies for lysosomal disorders and 12 additional rare diseases. The collaboration has been expanded from three to six programs for rare genetic diseases and now includes: Pompe disease, Fabry disease, CDKL5 deficiency disorder, Niemann-Pick Type C, Mucopolysaccharidosis Type IIIB, as well as a next generation program in Mucopolysaccharidosis Type IIIA. In addition to these three new programs, a discovery research agreement provides Amicus with exclusive disease-specific access to rights to collaborate with Penn's Gene Therapy Program to develop potentially disruptive new gene therapy platform technologies and programs. The agreement between Amicus and Penn is a Research, Collaboration and License Agreement, with funding provided to Penn to advance the preclinical research programs in the Wilson Lab and to license certain technologies invented under the funded Research Collaboration. Under a new five-year next-generation research agreement, Penn will conduct discovery research to develop potentially disruptive new gene therapy technologies. Amicus will continue to advance its own research and technology platforms to combine with Penn's technologies. Terms of the agreement include a $10M annual investment from Amicus, each year for five years, into GTP's discovery research program with the ability to extend. Amicus will receive exclusive disease-specific rights to collaborate with GTP to research and develop products for many lysosomal disorders.
|
CPRI | Hot Stocks06:39 EDT Capri Holdings reports inventory at March 30 of $953M, up 44.2% vs. prior year
|
CPRI | Hot Stocks06:36 EDT Capri Holdings CEO says 2019 was 'a transformational year' - John Idol, the company's Chairman and CEO, said, "Fiscal 2019 was a transformational year for Capri Holdings. We expanded our fashion luxury group with the addition of Versace, one of the world's most storied Italian luxury brands. Jimmy Choo delivered strong results and we continued to execute against Michael Kors' three strategic growth pillars of product innovation, brand engagement and customer experience. For the year, we were pleased that our luxury group delivered both double digit revenue and adjusted earnings per share growth." Idol continued, "Looking ahead, Fiscal 2020 will be an investment year for our group, and we believe our initiatives will deliver strong revenue growth for Capri Holdings. Longer term, our three brands position Capri Holdings to accelerate revenue from $6 billion to $8 billion dollars, which will be led by Versace and Jimmy Choo, with Michael Kors remaining a strong foundation for Capri Holdings. We expect to grow Versace from $900 million to $2 billion dollars in revenue, expand Jimmy Choo from nearly $600 million to $1 billion in revenue, while building Michael Kors from $4.5 billion to $5.0 billion in revenue. Taken together, we believe our three iconic, founder-led fashion brands position Capri Holdings to deliver multiple years of earnings growth."
|
EVH | Hot Stocks06:36 EDT Evolent Health to contribute $70M to Passport for 70% ownership interest - Evolent Health announced it has entered into a definitive agreement to partner with the current owners of Passport Health Plan in continuing to serve the Kentucky Medicaid market. The current owners, which include The University of Louisville, University of Louisville Physicians, University Medical Center, Jewish Heritage Fund for Excellence, Norton Healthcare and the Louisville/Jefferson County Primary Care Association, have been seeking a partner to provide expanded management and operational support, as well as capital through joint ownership of the health plan and have selected Evolent as its long-term financial and operating partner. Per the terms of the agreement, Evolent will acquire an ownership interest in Passport Health Plan and will expand the scope and term of its long-term management services agreement with the health plan. Passport will be jointly owned and operated in partnership between Evolent, The University of Louisville and other Passport owners. Passport is a Louisville-based health plan that serves more than 300,000 Medicaid beneficiaries and has provided managed care services in Kentucky for over 20 years. Evolent has provided services to Passport since 2016, when the organizations formed a relationship to launch the Medicaid Center of Excellence, focused on improving health outcomes for Medicaid beneficiaries in Kentucky and in several states nationwide. Since partnering with Passport, Evolent has directly engaged thousands of Passport members through clinical programs and a model of care in partnership with local providers. Per the terms of the agreement, Evolent will contribute $70M for a 70% ownership interest in Passport Health Plan and will also provide interim balance sheet support if necessary to meet near-term regulatory capital requirements. Evolent Health expects to account for its ownership interest in the joint venture as an equity method investment. Passport will be jointly owned and operated through a partnership between Evolent, The University of Louisville, University of Louisville Physicians, University Medical Center, Jewish Heritage Fund for Excellence, Norton Healthcare and the Louisville/Jefferson County Primary Care Association. The plan will be governed by a newly formed board of directors upon closing with joint representation from the current owners and Evolent Health. As part of the transaction, Evolent will expand its existing management services agreement with Passport, taking on additional responsibilities for day-to-day management of the health plan including administrative, clinical and financial operations and oversight. Evolent will also enhance its clinical scope with additional clinical program support, network optimization and specialty care management, specifically in oncology and cardiovascular services. The amended MSA will have a 10-year term. The agreement is subject to normal closing conditions including approval from several state and federal regulatory agencies.
|
RGS | Hot Stocks06:32 EDT Regis signs agreement for sale and conversion of 190 salons in Ohio - Regis has entered into an agreement for the sale and conversion of an additional 190 company-owned salons to its asset-light franchise portfolio substantially located in the state of Ohio and surrounding areas to the Super C Group. The salons being sold and refranchised are currently branded as Famous Hair, Best Cuts, Fiesta Salons, First Choice Haircutters and BoRics Hair Care. These salons will be remodeled and converted to Supercuts and Cost Cutters over the next several months. The transitions will begin in the Cleveland area in June. Earlier this year, the Super C Group purchased and converted sixty-six salons in Michigan to Supercuts. This agreement makes Super C the largest Cost Cutters franchisee for Regis.
|
MT | Hot Stocks06:19 EDT ArcelorMittal plans another round of European production cuts - Further to the announcement made on May 6, ArcelorMittal announces its decision to take additional steps to adjust its European production levels to further align its production to the current market demand. The company continues to be impacted by weak market demand and high import levels in Europe. As a result, ArcelorMittal will: Reduce primary steelmaking production at its facilities in Dunkirk, France and Eisenhuttenstadt, Germany; Reduce primary steelmaking production at its facility in Bremen, Germany in the fourth quarter of this year, where a planned blast furnace stoppage for repair works will be extended; Extend the stoppage planned in the fourth quarter of this year to repair a blast furnace at its plant in Asturias, Spain. Commenting, Geert van Poelvoorde, CEO, ArcelorMittal Europe - Flat Products, said: "This is again a hard decision for us to have taken but given the level of weakness in the market, we feel it is the prudent course of action. This will be a temporary measure that will be reversed when market conditions improve. In the meantime, our employees remain our utmost priority and we are doing everything we can to ensure that the right social measures are in place to support them and their families during this difficult time." On May 6, ArcelorMittal announced its intention to temporarily idle production at its steelmaking facilities in Krakow, Poland and reduce production in Asturias, Spain. The announcement also impacted the planned increase of shipments at ArcelorMittal Italia to a six million tonne annual run-rate; the planned increase will be slowed down following a decision to optimise cost and quality over volume in the current environment.
|
NSANY | Hot Stocks06:15 EDT Nissan's Infiniti to move headquarters back to Japan in mid-2020 - Nissan's Infiniti brand is moving its headquarters back to Japan from Hong Kong to create "more operational efficiencies" with its parent company. The premium brand has been headquartered in Hong Kong since 2012. The move is planned for mid-2020, the company said in a statement. "The relocation will further integrate IML with global design, research and development and manufacturing functions based in Japan. This connection is crucial as INFINITI ramps up development of its battery electric and e-POWER offerings. This move also will help increase efficiencies across the business in a hyper-competitive, disruptive industry." Reference Link
|
BMO | Hot Stocks06:06 EDT Bank of Montreal raises quarterly dividend by C$0.03 to C$1.03 per share - Bank of Montreal announced that its board declared a quarterly dividend of C$1.03 per share on paid-up common shares of Bank of Montreal for Q3, a C$0.03 increase from the previous quarter and up 7% from the prior year. The dividend on the common shares is payable on August 27, to shareholders of record on August 1. The dividends on the preferred shares are payable on August 26, to shareholders of record on August 1.
|
AMRN | Hot Stocks06:06 EDT Amarin's new drug application for vascepa granted Priority Review by FDA - Amarin's supplemental new drug application for Vascepa capsules has been accepted for filing and granted Priority Review designation by the FDA. The Prescription Drug User Fee Act goal date assigned by the FDA for this sNDA is September 28. Because of the Priority Review designation, the timing of this PDUFA date is four months earlier than the anticipated standard ten-month review for applications. Assuming FDA approval, Vascepa will be the first drug indicated to reduce residual cardiovascular risk in patients with statin-managed LDL-C cholesterol, but persistent elevated triglycerides, an indicator of cardiovascular disease. The sNDA for Vascepa is based on the landmark REDUCE-IT cardiovascular outcomes study. In REDUCE-IT, Vascepa achieved the primary endpoint with a 25% relative risk reduction compared to placebo in the first occurrence of a major adverse cardiovascular event in the intent-to-treat population. Vascepa ansp achieved the study's key secondary endpoint with a 26% relative risk reduction in 3-point MACE in the intent-to-treat population. Vascepa also achieved seven other secondary endpoints in the pre-specified hierarchical order below the key secondary endpoint, including a 20% relative risk reduction in cardiovascular death compared to placebo. Amarin believes an Advisory Committee meeting organized by the FDA in conjunction with its review of the expanded label for Vascepa is likely.
|
MORN | Hot Stocks06:04 EDT Morningstar to acquire DBRS for $669M - Morningstar announced it has entered into a definitive agreement to acquire DBRS, the world's fourth-largest credit ratings agency, for a purchase price of $669M. The combination of DBRS with Morningstar Credit Ratings' U.S. business will expand global asset class coverage and provide an enhanced platform for providing investors with leading fixed-income analysis and research. Morningstar intends to fund the transaction with a mix of cash and debt, which will include the placement of a new credit facility at closing. The transaction is expected to be accretive to net income per share in the first fiscal year after completion with an estimated closing in Q3, subject to regulatory approval and customary closing conditions.
|
BBBY | Hot Stocks06:02 EDT Bed Bath & Beyond appoints 4 new directors to board - Bed Bath & Beyond announced that four new independent directors have been appointed to the company's board "as part of the board's continued transformation." With these appointments, the board will comprise 13 directors, 12 of whom have joined the board within the past two years, 12 of whom are independent and seven of whom are women. All members of the board have been selected for their complementary skill sets and shared commitment to improve the company's performance and drive value for all Bed Bath & Beyond stakeholders as the business continues to evolve.
|
MSFT | Hot Stocks06:00 EDT LinkedIn acquires Drawbridge; financial terms not disclosed - LinkedIn announced in a blog post that it has entered into an agreement to acquire Drawbridge, Inc, a startup that helps companies with identity management using machine learning. "We believe Drawbridge's team and technology will allow us to accelerate the capabilities of our Marketing Solutions platform, helping our customers better reach and understand their professional audiences and measure the ROI of their campaigns across mobile and desktop. As we integrate Drawbridge's technology into LinkedIn following the closing of the transaction, we will continue to maintain the strong controls our members and customers have over the data they choose to share with us." Reference Link
|
AMZN | Hot Stocks05:58 EDT Twitch temporarily suspends new creators from streaming after troll attack - Twitch, a live streaming video platform owned Amazon, has disabled the ability for new accounts to live stream following an attack from trolls that flooded one section of the site with pornography, illegal content, and hateful imagery. In a statement via Twitter, Twitch said: "Over the weekend we became aware of a number of accounts targeting the 'Artifact' game directory to share content that grossly violates our terms of service. Our investigations uncovered that the majority of accounts that shared and viewed the content were automated. We are working with urgency to remove the offending content and suspend all accounts engaged in this behavior. In addition, we have temporarily suspended the ability for new creators to stream. We're very sorry for the inconvenience. The safety of our community is our top priority and we're doing everything we can to restore all access as quickly as possible. We will provide an update when we're able to do so." Reference Link
|
C BCYC | Hot Stocks05:54 EDT Citi appoints as depository bank for Bicycle Therapeutics ADR program - Citi (C), acting through Citibank N.A., has been appointed by Bicycle Therapeutics (BCYC) to act as depositary bank for its American Depositary Receipt programme. Each ADR represents one ordinary share of the company.
|
DVN CNQ | Hot Stocks05:52 EDT Devon Energy announces strategic exit of Canadian business for $2.8B - Devon Energy (DVN) announced that it has entered into a definitive agreement to sell its Canadian business to Canadian Natural Resources (CNQ) for $2.8B. This transaction is subject to customary terms and conditions and is expected to close by the end of Q2. Proceeds from the sale of Canada will be used for debt reduction. Additionally, the assets acquired include 1.5M acres of land, of which 1M acres are undeveloped.
|
DVN | Hot Stocks05:50 EDT Devon Energy announces strategic exit of Canadian business for $2.8B - Devon Energy announced that it has entered into a definitive agreement to sell its Canadian business to Canadian Natural Resources Limited for $2.8B. This transaction is subject to customary terms and conditions and is expected to close by the end of Q2. Proceeds from the sale of Canada will be used for debt reduction.
|
DVN | Hot Stocks05:50 EDT Devon Energy announces strategic exit of Canadian business for $2.8B
|
SPI | Hot Stocks05:49 EDT SPI Energy enters into security purchase agreement with Iliad Research - SPI Energy announced that it entered into a Security Purchase Agreement, or SPA, with Iliad Research & Trading. It further announced the completion of the closing of the transactions contemplated by the SPA. Pursuant to the terms of the SPA, SPI issued a promissory note in the original principal amount of $1.33M and received cash of $1.25M. Investor has the right to convert all or any portion of the outstanding balance into fully paid and non-assessable Ordinary Shares. The original conversion price is $10.00 per share, subject to adjustment for splits, dividends and similar events, and subject to downward adjustment to the conversion price of any subsequently issued convertible debt.
|
BTG | Hot Stocks05:35 EDT B2Gold says ISS, Glass Lewis recommend holders vote for ALL proposed items - B2Gold announced that Institutional Shareholder Services, or ISS, and Glass Lewis have both recommended that shareholders vote FOR the company's performance share unit plan as well as vote FOR all other proposed items to be considered at the upcoming Annual General & Special Meeting of Shareholders of B2Gold. B2Gold encourages shareholders to read the meeting material in detail.
|
AMGN | Hot Stocks05:34 EDT Amgen announces more irrevocable undertakings to accept offer for Nuevolution - Amgen announced a recommended public cash offer to the shareholders of Nuevolution AB to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash. Nuevolution's shares are listed on Nasdaq Stockholm, Small Cap. Subsequent to Amgen's announcement of the Offer, S-E-Bankens Utvecklingsstiftelse and SEB-Stiftelsen, Skandinaviska Enskilda Bankens Pensionsstiftelse, which own approximately 7% and 5%, respectively, of the outstanding shares and votes in Nuevolution, have under separate agreements undertaken to accept the Offer, subject to certain conditions. The irrevocable undertakings given by S-E-Bankens Utvecklingsstiftelse and SEB-Stiftelsen relate to their entire respective holdings of Nuevolution shares. The undertakings are conditional only upon the Offer being declared unconditional not later than September 1 and upon Amgen not committing any material breach of the Nasdaq Stockholm's Takeover Rules. As set out in the Offer Announcement, Sunstone LSV Fund I K/S, Skandinaviska Enskilda Banken AB and Stiftelsen Industrifonden, which own approximately 21%, 20% and 18%, respectively, or 59% in the aggregate, of the outstanding shares and votes in Nuevolution, have previously undertaken to accept the Offer on identical terms. Together, the irrevocable undertakings given by Sunstone, Skandinaviska Enskilda Banken AB, Industrifonden, S-E-Bankens Utvecklingsstiftelse and SEB-Stiftelsen correspond to approximately 71% of the total number of shares and votes in Nuevolution.
|
ENR | Hot Stocks05:20 EDT Energizer agrees to sell Europe-based Varta consumer battery unit for $401M - Energizer Holdings announced that it reached an agreement to sell the Europe-based Varta consumer battery business, including manufacturing and distribution facilities in Germany. The divestiture was made in accordance with the order imposed by the European Commission in connection with the company's acquisition of the battery and portable lighting business from Spectrum Brands in January. Energizer and VARTA AG, a German company active in the microbatteries and power & energy, have entered into a definitive agreement for the sale of the Varta Business, subject to purchase price adjustments. Pursuant to the terms of the acquisition agreement with Spectrum for Spectrum's global battery and lighting business, Spectrum will be contributing an additional $200M to Energizer in connection with the divestiture of the Varta Business. Anticipated net proceeds from the divestiture of the Varta Business are consistent with the assumptions we incorporated in our previously disclosed outlook for our leverage ratio at the end of FY19. As a result of the transaction, Energizer expects to record a loss related to the divestiture in discontinued operations during Q3. Energizer expects to close the transaction shortly after customary closing conditions are met and upon receipt of the EC's final regulatory approval.
|